``WEST VISAYAS STATE UNIVERSITY MEDICAL CENTER

E. LOPEZ ST., JARO, ILOILO CITY

“PHILHEALTH ACCREDITED HEALTH CARE PROVIDER”
DEPARTMENT OF PEDIATRICS
DAILY CENSUS

AUGUST 4-5, 2018, 7:00 AM TO 07:00 AM

CONSULTANT ON DECK
AREA/ON DUTY RESIDENTS PGI CLINICAL CLERKS
DR. HUBAG-PIALOGO / DR. CC DOJILLO
PEDIA ER -
PALEC CC HABARADAS
PICU/SICU/ICU-ISOL DR. ALMARZA
FLOORS
CC ENCARNACION
PERIPHERALS
PGI ESPORSADO
STA. TERESITA/ST. CAMILLUS DR. ONGLATCO
CC OCAMPO
PEDIA SERVICE WARD CC OTO
CC PATANGAN

NEW
DISCHARGED/
NEW REFERRAL/ OLD ABSCONDED /
ACCOMMODATION TRANSFER MORTALITY TOTAL
ADMISSION TRANSFER ADMISSIONS HAMA / SIGN OUT
OUT*
IN*
PSW A 0 2 11 2 0 0 11
PSW B 0 1 17 1 0 0 19
ISOLATION 0 1 2 0 0 0 3
PICU 0 0 2 1 0 0 2
SICU 0 0 2 0 0 0 2
ICU ISOL 0 0 0 0 0 0
PACU 0 0 0 0 0 0
4TH FLOOR 0 0 1 0 0 0
3RD FLOOR 0 1 1 0 0 0
SVFW 0 0 0 0 0 0
STW 1 1 5 0 0 0
SCW 1 0 3 0 0 0
FSSW/MSSW 0 0 3 0 0 0
OSW 0 0 1 0 0 0
OBSW 0 0 0 0 0 0
TOTAL 12 2 47 0 0 0

NEW ADMISSIONS -

ROOM PATIENT DATA DIAGNOSIS UPDATES SPECIAL ORDERS

CIC/RIC/CC
CABLORES, DENGUE F D5LR IL X 80CC/HR (3.3 CC/KG) STRICT MIO.
BEA FEVER WITH MONITOR ALL
DEPOSITARIO WARNING R URINE OUTPUT.
10/F/CHILD SIGNS NS1 DENGUE ANTIGEN: POSITIVE VOMITUS COUNT
750526 I DENGUE DoT IgG: NEGATIVE AT BEDSIDE.
CC: FEVER DR. DENGUE DoT IgM: POSITIVE WATCH OUT FOR
MINERVA PERSISTENT
C
VOMITING.
DOB: DR. 8/4/18 (1:41PM) HYPOTENSION
04/21/2008 ONGLATCO 113/0.35/4/42/1.40/0.40/0.48/0.02/0.05/0.00/0.05/25.70/78.10/32.90/77 (<90/60), COLD
DOA: H 8/5/18 (2:47 AM) CLAMMY
8/5/2018 119/0.36/4.63/2.07/0.42/0.02/0.43/0.04/0.05/0.00/0.04/25.70/78.40/32.80 EXTREMITIES,
/72.00 NARROW PULSE
WT: 24.3 KG PARACETAMOL 250MG/5ML, 5ML Q4H PRN FOR TEMP >/ PRESSURE,
M
HT: 129 CM 37.8C ABDOMINAL
O DISTENTION,
DECREASED
STRAW, HAZY, ACIDIC 6.0, 1.015, NEG SUGAR, NEG SENSORIUM,
N ALBUMIN, PUS CELLS 2-4, RBC 0-2, FEW AMORPHOUS BLEEDING, AND
URATES, FEW SE CELLS, FEW MUCUS THREADS. UNTOWARD
D SIGNS AND
SYMPTOMS

TRANSFER =
ROO DIAGNOSIS PENDING/SPECIAL
PATIENT DATA MANAGEMENT UPDATES
M CIC/RIC/CCIC ORDERS
PSWB4 MAGALLANES, ACUTE CNS F IVF: D50.3 NACL 1LX80CC/HR(MR+10%) HD8 MONITOR
To ANGEL INFECTION 7/22 SHIFT IVF TO D12.5 IMB X 20CC/HR (TFI 150) QHOURLY NVS
PSWA 9/F/CH 02 NP AT 2LPM WITH BP
749974 7/22 INCREASE O2 TO 10LPM VIA FACEMASK WATCH OUT FOR
R DECREASE IN
DR. 7/22 S/P INTUBATION, ET SIZE 3 LEVEL 9 CM, BAGGING RATE
DOB 09/18/08 MINERVA 60CPM AT 10LPM SENSORIUM,
DOA:7/20/201 DR. CEFTRIAXONE 1.6G IVTT Q12H D3 INCREASE IN ICP
I
8 ONGLATCO FOR PPD, SPUTUM AFB X 2 DETERMIAATIONS, GENE EXPERT
CC C
WT.32KG PATANGAN H
RANITIDINE 35MG IVTT Q8H
M
PARACETAMOL 300MG IVTT Q4H
O
GCS 14-15(E4V4M6)
N MANNITOL 100CC Q6H HOLD IF BP <90/60
DECREASE MANNITOL TO Q8H
D FULL DIET
D DIET AS TOLERATED
PSWB MAPILI, NEONATA F D50.3NACL 1L X 22CC/HR (TFI 150) HD 3 MINTOR Q4H AND
19 JULIANNE L SEPSIS - RECORD
CRIB 3 KHATE LATE R TSB FOR FEVER
TO LEONARDO ONSET R/O 37.8
I AMPICILLIN 175MG IVTT Q8H
PSW A ACUTE
CEFOTAXIME 175 MG IVTT Q8H
685477 CNS WATCH OUT FOR
7/26: INCREASE AMPICILLIN TO 500 MG IVTT Q6H
19D/F/CH INFECTIO ANY UNTOWARD
INCREASE CEFOTAXIME TO 500 MG IVTT Q6H
N S/SX
DOB: 7/04/18
BLOOD C/S: NO GROWTH AFTER 72 HOURS OF INCUBATION
DOA: 7/23/18 DR.
7/26: CSF GRAM STAIN KOH AFB INDIA INK: 0-1/OIF PUS CELLS
3.5KG MINERVA
GS: NO DEMONSTRABLE GRAM POSITIVE NOR GRAM
DR.
NEGATIVE ORGANISM
ONGLATC
AFB: NEGATIVE
O
KOH: NEGATIVE
CC
INDIA INK: NEGATIVE
C

H 7/23 CBC 116/0.34/3.53/15.66/0.33/0.55/0.05/0.06/0.1/551

M 7/23 S.NA: 135.6/SK:4.98 /CRP <6

THERMOREGULATE 36.5-37.5C

N CSF PROTEIN: 83.11

CSF ANALYSIS: ABOUT 1 CC| XANTHOCHROMIC| SLIGHTLY
HAZY| CELL COUNT 5.00 | RBC 33.00| LYMPHOCYTES 100.00|
FLUID SUGAR 2.56| SERUM SUGAR 17.76
D BREAST FEED PER DEMAND
FULL TO C
PSW-B MASICAMPO ACUTE F D5LR 1L X 80CC/H + 3 MEQS KCL/100CC IVF MGH MONITOR Q4H
12 AIMEREE GASTROE WATCH OUT FOR
TO EVE NTERITIS R DECREASED
PSW A VILLAREAL WITH ACTIVITY,
I AMPICILLING 250 MG IVTT Q6H
1/F/CH MODERAT VOMITING, LOOSE
750329 E STOOL,
DEHYDRA C HYPOTENSION
DOB: 10/1/16 TION; 7/30 CBC: VOMITUS AND
DOA: 7/29/18 PCAP B; H STOOL COUNT AT
117/0.30/4.28/7.65//0.61/0.30/0.00/0.09/0.00//27.40/71.00/38.60/465
HYPOKAL KCL TAB 1 TAB PO TID BEDSIDE
CC: LOOSE EMIA M
PLR TO REPLACE GI LOSSES PER VOLUME
STOOLS SECONDA 7/29 FECALYSIS: GRN/MUCOID/NO OVA/ MANY/0-3/1-3
RY O
HTL 78CM N
WT: 9.2KG DR.
MINERVA
DR.
ONGLATC
O D
CC
PATANGA
N

PSW A = 12
DIAGNOSIS
ROOM PATIENT DATA MANAGEMENT UPDATES SPECIAL ORDERS
CIC/RIC/CCIC
PSWA INTREPIDO, DENGUE FEVER F D5LR 1L X 66 CC/HOUR (4CC/kg) (+) CONTINUE CBC PLT
1 PRECIOUS WITH WARNING R HERMA'S MONITORING Q8H
KYLE SIGNS 8/1/2018DENGUE NSI (+) RASH ON STRICT MIO
I IgG AND IgM (-) THE NECK MONITOR ALL URINE
6 /F/CHILD DR. MINERVA AMPICILLIN SULBACTAM 750 MG IVTT Q 7 HOURS ANST AND OUTPUT AND
750432 DR. ONGLATCO C ARMPITS RECORD. PROVIDE A
 7/31/2018 APTT 42.1 CONTROL 34.5 CALIBRATED BOTTLE
CC: CC OCAMPO PROTIME 15.3, % ACTIVITY 73.0, INR 1.22, NORMAL CONTROL 90.0 AT BEDSIDE. ORS TO
VOMITING 8/3/18 APTT 44.2 CONTROL 34.7 REPLACE GI LOSSES
PROTIME13.1, %ACTIVITY 100.0 ,INR 1.00, NORMAL CONTROL 92.0 VOL/VOL. PLR TO
DOB:4/7/12 8/2/18 CBC REPLACE LOSSES IF
DOA: 126/0.39/4.92/3.82/0.61/0.28/0.00/0.07/0.01/0.03/25.60/78.20/56.00 ORS IS NOT
7/31/2018 7/31/18 CBC / TOLERATED. STOOL
115/035/4.50/5.79/0.81/0.10/0.00/0.10/0.00/25.50.77.10/33.10/215/ AND VOMITUS
WT: 16.51 KG 8/1/18 CBC 115,0.34, 4.44, 3.70, 0.70, 0.20, 0..00, 0.10, 0.00, 26.00, 77.50, COUNT AT BEDSIDE.
LT: 106 CM 33.50, 255 WATCH OUT FOR
8/2/18 CBC 120, 0.36, 4.65, 2.94, 0.55, 0.02, 0.32, 0.00, 0.04, 0.00, 0.07, HYPOTENSION (BP
25.70, 77.50, 33.20, 93.00 <90/50), BLEEDING,
H 8/3/18(4:21AM) CBC 118, 0.35, 4.56, 3.21., 0.31, 0.01, 0.60, 0.00, 0.02, ABDOMINAL
0.00, 0.06 DISTENTION, COLD
8/4/18 (6:30AM) CBC AND CLAMMY
136/0.40/4.38/5.10/0.18/0.75/0.01/0.06/0.00/0.04/25.70/77.60/33.20/20 EXTREMITIES,
8/4/18 (3:28 PM) CBC THREADY PULSES,
113/0.34/4.42/6.47/0.12/0.48/0.02/0.06/0.05/25.50/77.60/32.90/26.00 DECREASE IN
8/4/18 (11:10PM) CBC SENSORIUM, AND
115/0.35/4.50/7.18/0.35/0.49/0.04/0.05/0.02/0.05/25.50/77.30/33.00/29 OTHER UNTOWARD
8/5/18 (9:37PM) CBC SIGNS AND
112/0.33/3.53/5.20/0.19/0.79/0.00/0.02/0.00/26 SYMPTOMS
8/3/18 BLEEDING TIME 2, CLOTTING TIME 4, LEE WHITE 0
8/4/18 CETIRIZINE 5 MG/ML, 4 ML OD 1ST DOSE NOW
8/5/18 112/0.33/3.53/5.20/0.19/0.79/0.00/0.02/0.00/26.00
8/2/18 PARACETAMOL 170 MG IVTT Q4H PRN FOR FOR T>37.8 C
RANITIDINE 20 MG IVTT Q 8 HOURS
M
PLEASE GIVE VITAMIN K 10 MG AS VERY SLOW IV PUSH OD
CETIRIZINE 5MG/5ML, 4ML OD
7/31/2018 7:27 PM U/A STRAW,HAZY, ACIDIC 6.5, 1.015, SUGAR NEGATIVE,
PROTEIN NEGATIVE, PUS CELLS 1-2, RBC 25-30, AMORPHOUS URATES
OCCASIONAL, SQUAMOUS EPITHELIAL CELLS OCCASIONAL
O 7/31/2018 10:51 PM U/A STRAW,HAZY, ACIDIC 6.5, 1.015, SUGAR
NEGATIVE, PROTEIN NEGATIVE, PUS CELLS 1-2, RBC 25-30, AMORPHOUS
URATES OCCASIONAL, SQUAMOUS EPITHELIAL CELLS OCCASIONAL

N
D NO DARK COLORED FOOD
O 7/29 UA: STRAW/HAZY/6.5/1.015/-/-/0-2/10-25/FEW/MANY/OCC
N

D NO DARK-COLORED FOODS
PSWA F
3 R
I
C
H
M
O
N
D
PSWA ARILLO, DENGUE FEVER F IVF D5LR 1L X 140 CC/HR HD 2 STRICT MIO.
4 JAYMAR WITH WARNING R MONITOR URINE
14YO/M/CHIL SIGN DENGUE NSI (+) REPEAT CBC OUTPUT AND
D I WITH PLT RECORD. PROVIDE A
IgG AND IgM (-)
750447 DR.MINERVA C AT 6AM CALIBRATED BOTTLE
DR. ONGLATCO 8/1 154/0.46/9.09/73/19/152/141.30/3.85/2.32 AT BEDISDE
CC: CC PATANGAN 8/3/2018 (6AM) CBC 125/ PLR TO REPLACE GI
VOMITING 0.37/4.40/2.29/0.56/0.27/0.00/0.11/0.01/0.05/28.40/83.40/34.10/135.00 LOSSES
AND 8/3/18(9:19PM) CBC VOLUME/VOLUME
ABDOMINAL H
127/0.38/4.51/2.84/0.52/0.38/0.00/0.10/0.00/28.20/83.80/33.70/109
PAIN 8/5/18 WATCHOUT FOR
DOB: 137/0.40/4.80/6.32/0.30/0.56/0.10/0.02/0.00/0.02/28.50/83.20/34.20/56 PERSISTENCE OF
12/11/2003 00 ABDOMINAL PAIN,
DOA: 8/1 Na: 141.30, K: 3.55, Ca 2.32 VOMITING,
8/1/2018 M PARACETAMOL 300 MG IVTT Q8H PRN FOR T>37.8 WHILE ON NPO HYPOTENSION,
PARACETAMOL 250 MG/5ML Q4H PRN FOR FEVER ONCE ON DIET NARROW PULSE
WT: 28 KG 8/1 URINALYSIS REQUESTED PRESSURE, THREADY
HT 146 CM FECALYSIS PULSES,
O PROLONGED CRT,
8/3 FECALYSIS YELLOW BROWN, LOOSE, NO OVA OR PARASITE SEEN
COLD CLAMMY
N EXTREMITIES,
 BLEEDING,
DECREASE
SENSORIUM AND
OTHER UNTOWARD
SIGNS AND
D SYMPTOMS

MAY GARGLE WITH

WARM WATER WITH
SALT FOR ORAL
HYGIENE
PSWA MACHICA, IgA F HEPLOCK HD 2 FOR DISCHARGE
5 KEN RYAN NEPHROPATHY R 8/1/18 CXR PA/LATERAL LT: NEGATIVE CP FINDINGS
12YO/M/CHIL STEROID I
D RESISTANT; S/P C WATCHOUT FOR HEADACHE, HYPOTENSION, AND ARRHYTHMIA
750424 IV H
CC: FACIAL METHYLPREDNI 8/2 IV METHYLPREDNISOLONE 900 MG DISSOLVED IN 100 ML D5W TO RUN
SWELLING SOLONE PULSE FOR 2HRS X DAYS
THERAPY X 3 8/3/18 CALCIUM TAB, 1 TAB OD/ AMLODIPINE 5MG/TAB, 1 TAB OD/
DOB: CYCLES M
METHYPREDNISOLONE 16 MG/TAB, 1 TAB TID EVERY OTHER DAY/ IV
10/26/2005 METHYLPREDNISOLONE 900 MG DISSOLVED IN 100 ML D5W TO RUN FOR
DOA: 8/1/18 DR. VILLARTE 2HRS X 3 DAYS
DR. ONGLATCO O 8/2/18 FECALYSIS BROWN/SOFT/ NO OVA OR PARASITE SEEN
WT: 31KG CC OCAMPO N
HT:131CM
D
PSWA ALMIRANTE, ACUTE CNS F D5 0.3 NACL X 60 CC/ML HD 37 STANDBY
6 RUNNIEL INFECTION T/C D5IMB 1L X 65 CC/HR INTUBATION SET
5Y/M/CH JAPANESE 7/13 CHANGE IV TUBINGS, IV BOTTLE, SOLUSET Q5DAYS
ENCEPHALITIS, 7/24: D5IMB 1LX 53CC/HR (MR) POST ELEVATE HEAD OF
CC: FEVER HEALTH CARE 8/3/18 D5IMB 1L X 53CC/HR EXTUBATIO BED TO 30⁰
ASSOCIATED R 06/30 INTUBATE PX WITH ET SIZE 4.5 LEVEL 15. BAGGING RATE 30/HR. FIO2 N
DOB: 8/12/18 INFECTION- 100% DAY 17 MIO Q 4 HOURLLY
DOA: PNEUMONIA 07/02 S/P REINTUBATED ADJUSTED ET LEVEL TO LEVEL 17, O2 AT 10 LPM AND RECORD
06/27/18 AMBUBAGGING 7/25: MONITOR NVS Q
S/P EXTUBATION 07/02 FOLKS APPRAISED FOR VENTILATOR TANSFER TO HOURLY AND
HT: 114 CM (7/14/2018) 07/02 PAI WITH SALBUTAMOL 1 NEB Q2H PSWA RECORD
WT: 15.5 KG S/P LUMBAR CHEST PHYSIOTHERAPY AND SUCTIONING OF SECRETIONS
PUNCTURE 07/04 REDUCE O2 AT 8 LPM CHANGE SUCTION
O7/06 REDUCE BAGGING RATE TO 30CPM CATHETERS DAILY
DR. MINERVA 07/06 REDUCE NEBULIZATION TO Q4H
DR. ONGLATCO 7/09 D/C PAI SALBUTABOL SUCTIOING AT
CC OCAMPO 07/09DECREASE 02 AT 5LPM LEAST Q HOURLY
7/12 PAI WITH SALBUTAMOL 1 NEB NOW. CHEST PHYSIOTHERAPY REFER FOR
THEREAFTER DESATURATION
7/14 FOR EXTUBATION1H AFTER 4TH DOSE OF DEXAMETHASONE. O2SAT <95% OR RR
CONTINUE DEXA,ETHASONE OR 4 MORE DOSES Q6H POST EXTUBATION AT >30
8MG IVTT. PAI WITH SALBUTAMOL 20 MINS AFTER EXTUBATION THEN Q6H;
CHEST PHYSIOTHERAPY AFTER EVERY NEBULIZATION. W/O FOR
REPEAT CHEST XRAY PAKL AFTER EXTUBATION. PERSISTENCE OF
REPEAT ABG 1 HOUR AFTER EXTUBATION AT 10 LPM O2. FEVER, FURTHER
7/14 CXR PA ATELECTATIC CHANGES, LEFT LOWER LUNG, RESOLVED. DECREASE IN
PNEUMONIA WITH BILATERAL PROGRESSION IN THE RIGHT. MINIMAL SENSORIUM,
PLEURAL EFFUSION VS REACTION, LEFT DESATURATION
7/15 PAI WITH SALBUTAMOL Q20MINUTES X 3 DOSES. CONTINUE
NEBULIZATION Q4H AFTER 3 DOSES CONTINUOUS TSB IF
7/16 REVISE NEBULIZATION: PAI WITH SALBUTAMOL Q6H TO ALTERNATE FEBRILE
WITH 1 NEBULE SALBUTAMOL + IPATROPIUM Q6H
7/16 DECREASE O2 TO 9 LPM THIS AM THEN 8 LPM THIS PM
7/18 DECREASE O2 TO 6 LPM BY 3 PM | REVISE NEBULIZATION TO PAI WITH
1 NEB SALBUTAMOL Q8H ALTERNATE WITH 1 NEB SALBUTAMOL +
IPATROPIUM Q8H
7/19 DECREASE O2 TO 5 LPM. REVISE NEBULIZATION: 1NEB SALBUTAMOL
Q12H, ALTERNATE WITH 1 NEB SALBUTAMOL + IPATROPIUM Q12H
7/19 CXR APL: PNEUMONIA, BILATERAL, WITH PROGRESSION. MINIMAL
PLEURAL EFFUSION, BILATERAL, WITH REGRESSION IN THE LEFT AND
PROGRESSION IN THE RIGHT
7/20 INCREASE NEBULIZATION TO Q8H ALTERNATING WITH 1 NEB
SALBUTAMOL WITH SALBUTAMOL + IPATROPIUM
7/21 DECREASE O2 TO 4 LPM VIA NASAL PRONG
7/22 DECREASE O2 TO 3 LPM VIA NASAL PRONG
7/23 DECREASE O2 TO 2 LPM
7/24 DECREASE 0O2 TO 1 LPM VIA NASAL PRONG
D/C SALBUTAMOL + IPATROPIUM NEBULIZATION
7/25: DECREASE O2 TO 0.5 LPM
8/2 REPEAT CXR APL
8/4/18 DISCONTINUE O2
I 0 DECREASE O2 TO 0.5 LPM7/1 START AMIKACIN 225 MG IVTT OD (44.5
MKDAY)
07/02 SHIFTED CEFTRIAXONE TO MEROPENEM 620 MG IVTT Q8H (40
MKDOSE)
07/02 STILL FOR LP ONCE STABLE
07/02 TRACHEAL ASPIRATE NEGATIVEKOH AND AFB,
07/07 START SUCRALFATE 250 MG/PPTAB, 1 PPTAB Q6H VIA NGT
7/08 START FLUCONAZOLE 95MG/PPTAB, 2 PPTABS AS LOADING DOSE
THEN 1 PPTAB AS MAINTENANCE DOSE OD, + URINE KOH, + A. BAUMANNII
ON ETA
07/08 SHIFT AMIKACIN TO GENTAMICIN 40MG IVTT, NST Q8H
07/08 START CIPROFLOXACIN 500 MG/TAB, 1/2 TAB Q12H VIA NGT
MEROPENEM 620 MG IVTT Q8H (40 MKDOSE)
7/13 APPLY MUPIROCIN ON PREVIOUS IV SITES TID
7/20 D/C CIPROFLOXACIN. START LEVOFLOXACIN 500MG/TAB 1/4 TAB BID X
14 DAYS
7/22 CSF C/S: NO GROWTH AFTER 3 DAYS OF INCUBATION
7/23 D/C GENTAMYCIN
8/3/18 LEVOFLOXACIN D14/ FLUCONAZONE D2
C 7/25 D/C CARDIAC MONITOR
H 06/30 113/33/4.12/10.47/84/13/00/03/00 27.60/79.80/34.50 191
6/27 141/0.37/4.60/9.92/0.74/0.21/0.00/0.05/0.00 30.60/79.80/38.30/164
6/30 113/0.33/4.12/10.47/0.84/0.13/0.00/0.03/0.00 27.60/79.8/34.5/191
7/8 109/0.32/3.98/11.42/0.80/0.15/0.00/0.05/0.00 27.50/81.00/33.90/632
7/13 121/0.35/4.23/12.12/0.90/0.07/0.01/0.02/0.00 28.5/83.4/34.2/579
7/17 126/0.37/4.39/11.35/0.75/0.16/0.01/0.08/0.00 28.7/83.2/34.5/356
7/19 122/0.35/4.19/11.27/0.77/0.17/0.01/0.05/0.00
29.10/82.90/35.10/272
7/25 127/0.36/4.39/6.29/0.75/0.17/0.01/0.07/0.00/29.0082.40/35.20/322
M 07/04 INCORPORATE 2 MEQS KCL/100 CC OF IVF

06/27 CREATININE 33.94

07/01 K 4.08
START NGT FEEDING W/ HOMEMADE F75 RECIPE
8/4/18 STOOL EXAM: NO OVA OR PARASITE SEEN
O FOLEY CATHETER INSERTED
06/27 STRAW/HAZY/6.0/1.015 (-)/(-) 3-8/1-3 FEW/FEW
FOR RPT URINE KOH, FECALYSIS
7/11 URINALYSIS PSTRAW/ HAZY/ PH 7.0/ SG 1.020/ NEG SUGAR/ NEG
ALBUMIN/ PC 1-3/ RBC 12-20/ AP MANY/ SEC OCC
7/13 CHANGE FOLEY CATHETER Q7DAYS
7/13 URINALYSIS PSTRAW/ HAZY/ PH 7.5/ SG 1.020/ NEG SUGAR/ NEG
ALBUMIN/ PC 1-4/ RBC 12-20/ AP MANY/ SEC FEW/
7/21: PSTRAW/SHAZY/ PH 6.0/ SG 1.015/ NEG SUGAR/ NEG ALBUMIN/ PC
2-4/ RBC 1-2/ AU OCC/ SEC OCC
7/24 PULL OUT FC
7/24 URINALYSIS PSTRAW/ HAZY/PH 8.0/1.010/NEG SUGAR/ NEG
ALBUMIN/ PC 0-2/ RBC 80-95/ AP: MANY/ SEC FEW
7/25: URINALYSIS PSTRAW/SHAZY/PH 5.0/1.010/NEGATIVE SUGAR/
NEGATIVE ALBUMIN/ PUS CELLS 0-2/ RBC 0-2/ AMORPHOUS URATES OCC/
SEC OCC
8/2 START FUROSEMIDE 150 MG/TAB, 1 TAB OD
N 06/27 MANNITOL 78 CC IV PUSH GIVEN
06/28 IDEALLLY FOR LP, DEFERRED DUE TO CEREBRAL EDEMA
06/28 MANNITOL 75CC IV PUSH Q6H (5CC/KG), MAY GIVE MANNITOL AS IV
DRIP
06/29 GIVE MANNITOL AS IV PUSH
07/08 DECREASE MANNITOL TO Q8H
MANNITOL 75CC IVTT Q8H (4.8 CC/KG)
7/13: DECREASE MANNITOL TO Q12H
7/18: CSF PROTEIN 351.49
7/20 DECREASE MANNITOL TO OD
7/24 D/C MANNITOL
 D 06/30 INSERT NGT FOR GRAVITY DRAIN
07/09 START ENTERAL FEEDING
7/13 START DEXAMETHASONE 8 MG IVTT Q6H
7/13 FOR DAILY BEDSIDE REHAB
7/13: NGT FEEDING WITH HOMEMADE F75 RECIPE: 4 TBSP SKIM MILK| 1
TBSP + T SP COCONUT OIL| 4 TBSP SUGAR | 8 TBSP RICE GRUEL OR
POWDER (TO MAKEW 1 C-GRUEL RICE + 6 CUPS WATER BOILED TO
MEDIUM CONSISTENCY) | WATER 1000ML. FEED 300 ML Q4H OF F75
RECIPE VIA NGT.
D/C MILK ONCE F75 IS STARTED
7/16 VITAMIN K 1 MG AS VERY SLOW RETROGRADE IV PUSH
7/17 START ZINC SYRUP 5ML OD VIA NGT. START MTV L+ LYSINE SYRUP 5
ML OD
7/23 REVISE FEEDING TO F10D WITH FF RECIPE: 6 TBSP SKIMMED MILK + 4
TBSP SUGAR + 4 TBSP VEGETABLE OIL, ADD WATER TO MAKE 1000ML. GIVE
300 ML Q4H VIA OGT
7/25 GIVE VITAMIN K 1 MG AS VERY SLOW RETROGRADE IV PUSH
7/25 START KCL TAB, 1 TAB TID. APPLY MUPIROCIN ON ALL PREVIOUS IV
SITES TID
8/4/18 INCREASE FEEDING TO Q2H
PSWA MAGALLANES ACUTE F FOR FOR DISCHARGE
7 , ANGEL BACTERIAL R DISCHARGE
9 MENINGITIS; I
YO/FEMALE/ PEDIATRIC C
CHILD COMMUNITY H
749974 ACQUIRED M
CC: FEVER PNEUMONIA – C O
N
DOB: DR. MINERVA
D
9/18/2006 DR. ONGLATCO
DOA:
7/20/2018

WT: 32 KG
HT:162CM
PSWB FUENTES, PCAP-C F D50.3NACL 1L X 45CC/HR (MR+20%) MIO QSHIFT AND
9 JENNIA R PAI 1 NEB SALBUTAMOL Q4H RECORD
EUNICE DR. MINERVA NACL SPRAY, 1 SPRAY PER NOSTRIL Q1DAY MONITOR VS Q4H
ARCETA DR. ONGLATCO I AMPICILLIN SULBACTAM 375MG IVTT ANST Q6H (111MKDAY) AND RECORD
MAY GO
1/F/CHILD CC OTO C WITH O2 SAT
HOME
733583 O2 @ 2 LPM
H 7/30 CBC: 121/0.36/4.61/8.23//0.51/0.4/0/0.09/0//26.2/78.6/33.3/281 WITH
WATCH OUT FOR
M PARACETAMOL 250MG/5ML, 2ML Q4H PRN FOR TEMP >/= 37.8 HOME
TACHYPNEA,
CC: COUGH 7/30 NA: 140.3 K: 4.71 MEDS
DOB,
O PLEASE
PERSISTENCE OF
DOB: N TRANSFE
COUGH AND
06/30/17 D FEED WITH STRICT ASPIRATION PRECAUTIONS, HOLD IF RR >/= R TO PSW
FEVER, AND
DOA: 7/30/18 30CPM A
OTHER
DIET FOR AGE UNTOWARD S/SX
WT:
HT:
PSWA F
8 R
I
C
H
M
O
N
D
PSWA CAYACAY, BONE MARROW IVF: D5LR 1L X 120CC/HR (5CC/KG) L HD 17 FOR DISCHARGE
9 JEMUEL FAILURE; SEPTIC PLR 1L @KVO R
LOZADA SHOCK F 7/18 IVF R D5LR 1L X 68CC/HR (3CC/KG) CEFTAZ D11
749819 SECONDARY TO L HEPLOCK AMIK D10
11/M/CJILD CULTURE DECREASE IVF TO KVO THEN SHIFT TO HEPLOCK
PROVEN SEPSIS 7/17: CXR – NORMAL PARACETAM
R
CC: FEVER (PSEUDOMONA O2 AT 2LPM OL
S AERUGINOSA) 7/17: CEFTRIAXONE 2.25G IV Q24H (100MKDAY) 250MG/5M
DOB: 7/21: SHIFT CEFTRIAXONE TO CEFTAZIDIME 1.2G IV Q8H ANST (160MKDAY) L; 4.5 Ml
2/10/2007 I Q4H
START AMIKACIN 350MG IV Q24H NST (15.6MKDAY)
DOA: 7/17/18 8/1 PLEASE FOLLOW-UP BLOOD CS RESULT
C
 WT: 22.5KG DR. VILLARETE 7/17 CBC:
HT: 125CM DR. SILVA 61/0.16/2.12/0.60//0.16/0.73/0.02/0.04/0/5//28.60/75.80/37.70/5/5
CC PALABRICA 7/18 CBC: 62|0.17|2.21|0.38||27.90|76.90|36.20|9
7/18 CBC: 60/.17/2.14/0.51//0.28/0.62/0.02/0.03/0.05//8/6/5
7/20 CBC: 60/0.17/2.14/0.51//0.28/0.02/0.02/0.03/0.01//6
7/21 CBC:
104/0.29/3.71/1.78//0.26/0.01/0.70/0/0.01/0/0.02//28/78.10/35.90//11
7/27 CBC: 108|0.30|3.78|2.24|0.17|0.75|0|0.04|0|0.04|28.50|78.90|
36.10|34
FOLLOW UP SERUM NA, K, APTT, PROTIME, DENGUE COMBO TEST, SERUM
ALBUMIN
H 7/17 APTT: 47.9/33.5 PROTIME: 16.0/68/1.28/93
PBS: SEVERE PANCYTOPENIA
7/18 PT: 16.3/68%/1.29/94
DENGUE COMBO TEST NEGATIVE+
BLOOD CS: ALARM 15H 55 MINS INCUBATION
GROWTH PSEUDOMONAS AERUGINOSA
S - AZTREONAM, PIPERACILLIN, AMIKACIN, CEFTAZIDIME, GENTAMICIN,
MEROPENEM, LEVOFLOXACIN, TOBRAMYCIN, CEFEPIME, CIPROFLOXACIN,
PIP-TAZ
8/2
102/0.28/3.50/1.44/0.55/0.08/0.27/0.00/0.03/0.00/0.07/29.10/79.90/36.4
0/96.00
PARACETAMOL 250/5ML 4.5ML Q4H PRN TEMP ≥37.8
7/17 NA: 128.70; K: 3.16 ; ALBUMIN 26.74
VIT K LONG IV PUSH
M KCL TABS 1 TAB TID
8/1 START PREDNISONE 20MG/TAB, 1 TAB IN AM AND PM
THEN PREDNISONE 10 MG/TAB, ½ TAB IN AM
8/3/18 PREDNISONE D2/ CEFTAZIDIME D12+1/ AMIKACIN D13
O 8/2 U/A: PSTRAW/SHAZY/ACIDIC 6.0/1.015/NEG/NEG/0-2/0-2/FEW/FEW
N
D
PSWA MASICAMPO, ACUTE F D5LR 1L X 80CC/H + 3 MEQS KCL/100CC IVF HD5 MONITOR Q4H
10 AIMEREE EVE GASTROENTERIT R TRANSFERR WATCH OUT FOR
VILLAREAL IS WITH I AMPICILLING 250 MG IVTT Q6H ED FROM DECREASED
1/F/CH MODERATE C PSW B ACTIVITY, VOMITING,
750329 DEHYDRATION; H 7/30 CBC: LOOSE STOOL,
PCAP B; 117/0.30/4.28/7.65//0.61/0.30/0.00/0.09/0.00//27.40/71.00/38.60/465 MAY GO HYPOTENSION
DOB: 10/1/16 HYPOKALEMIA M KCL TAB 1 TAB PO TID HOME VOMITUS AND
DOA: 7/29/18 SECONDARY PLR TO REPLACE GI LOSSES PER VOLUME STOOL COUNT AT
O 7/29 FECALYSIS: GRN/MUCOID/NO OVA/ MANY/0-3/1-3 BEDSIDE
CC: LOOSE DR. MINERVA N
STOOLS DR. ONGLATCO
D
CC PATANGAN
HTL 78CM
WT: 9.2KG
PSWA FABAY, AL NEPHROTIC F INSERT SALINE HEPLOCK HD 4 MONITOR VS
11 ROMAR SYNDROME; R CXR: BRONCHOPNEUMONIA; PLEURAL EFFUSION, R QHOURLY AND
PATANI URINARY TRACT I CEFUROXIME 250MG/5ML, 6ML BID (40MKDAY) CEFUROXIM RECORD
4/M/CHILD INFECTION- C E D0+1 STRICT MIO AND
697888 RESOLVING; S/P H 7/30 CBC: 113/0.32/4.25/6.82//0.72/0.22/0/0.06/0//26.5/74.3/35.7/289 RECORD AT BEDSIDE
2 UNITS PREDNISONE 10MG/5ML, 10ML BID WATCH OUT FOR
CC: ALBUMIN M 7/30 NA: 137.3 K: 4.81 PROGRESSION OF
ABDOMINAL TRANSFUSION; 7/31 ALBUMIN: 16.46 EDEMA,
DISTENSION PEDIATRIC O 7/31 UA: STRAW/HAZY/6.5/1.020//-/3+/0-3/8-15//FEW/FEW/MANY HYPERTENSION
COMMUNITY N (>110/70), DOB, IF
DOB: 8/28/18 ACQUIRED URINE OUTPUT <
NO DARK COLORED FOOD
DOA: 7/30/18 PNEUMONIA-A 20CC PER SHIFT
LET PATIENT WEAR
WT: 17 KILOS DR. VILLARETE D MASK AT ALL TIMES
HT: 101 CM DR. SILVA
CC PALABRICA
PSWA SATURINAS, ACUTE IVF: D5LR 1L X 58CC/HR (30/6) HD 18 REPLACE GI LOSS
12 KEO GASTROENTERIT 7/17: DECREASE IVF RATE TO KVO FFUP WITH PLR
MAGADA IS WITH MILD F 7/31: D50.3NACL 1L X 45 CC/HR (MR) DIFFERENTI STOOL AND
4/MCHILD DEHYDRATION; 8/1 SHIFT TO IV HEPLOCK AL COUNT VOMITUS COUNT AT
748275 TO CONSIDER 8/5/18 START LINE: D50.3NACL 1L X 50CC/HR (MR +10%) BEDSIDE
ACUTE MYELOID O2 AT 2 LPM VIA NASAL PRONG RPT
LEUKEMIA; R 7/17 CXR: BRONCHOPNEUMONIA, WITH REGRESSION PROTIME
8/5/18 FOR CHEST XRAY PAL ADTER D3
 CC: LOOSE DOWN 7/17: START METRONIDAZOLE 350MG IV Q8H NST (30MKDAY) OF VIT K
STOOLS WITH SYNDROME 7/18 C/S Report: alarm detected at 27hr & 5mins of incubation
FEVER 7/19 START DIXOXANIDE 125MG/5ML 3ML TID (20MKDAY) FOR UA
DR VILLARETE 7/21 BLOOD CS FINAL REPORT STAPHYLOCOCCUS HOMINIS UKOH FA
DOB: DR SILVA 7/22 MUPIROCIN OINTMENT ON PREVIOUS IV SITE TID
11/5/2013 CC PALACIOS 7/22 START VANCOMYCIN 200MG IV Q6H NST (17.4 MKDOSE) TO BE GIVEN RESUME
DOA: OVER 60 MIN VIA SOUSET PARACETAM
7/16/2018 7/22 START GENTAMICIN 30 MG IV Q8H (7.8MKDAY) OL
7/25 INCREASE O2 TO 4LPM
WT:11.5 KG 7/30 STOO CS: HEAVY GROWTH OF ENTEROBACTER AEROGENES
7/31 START CIPROFLOXACIN 250MG/TAB 1/4 TAB Q12H (21.7MKD)
7/31 D/C METRONIDAZOLE AND DILOXAMIDE STOCKS
I
7/31 FOLLOW UP BLOOD CS RESULT
7/31 REVISECIPORFLOXACIN 500 MG/TAB ¼ TAB Q12H
7/31 REFERAL TO INFECTIOUS AND CLEARED FOR CHEMOTHERAPY
8/1 DAY 1 OF NAPROXEN TEST
8/5/18 MAY GIVE PARACETAMOL 120MG IVTT Q6H PRN T>=37.8C IF
CANNOT TOLERATE PO
8/5/18 SHIFT VANCOMYCIN TO LINEZOLID
8/5/18 START LINEZOLID 40 MG IVTT Q8, ANST (10MKD)
8/5/18 MAY GIVE/USE VANCOMYCIN IF LINEZOLID IS UNAVAILABLE
8/5/18 DISCONTONUE CIPRROFLOXACIN
8/5/18 CONTINUE GENTAMYCIN
8/5/18 START MEROPENEM 230 MG IVTT Q8H, ANST (20MKDOSE)
C
7/17: REQUEST 1 PRBC OF PT’S BLOODTYPE TP BE DIVIDED INTO 3
ALIQUOTS AND TO BE TRANSFUSED INITIALLY AT5CC/KG THEN 9CC/KG AND
14 CC/KG Q12H APART
7/17 CBC
36/0.12/1.36/15.71/2.00/0.01/0.31/0.00/0.00/0.00/26.70/85.20/31.30
STAB 0.01
MYELOCYTE 0.01
BLAST 0.13
ATYPICAL LYMPHOCYTES 0.53
MANUAL PLATELET CT: 47.00
7/22 CBC: 90|0.27|3.04|1.87|0.35|0.62|0.00|0.02|0.00|0.01|29.50|
89.80|32.90| 35
H 7/19 BT 60 CC pRBC
7/20 BT 105 CC pRBC
7/21 BT 160 CC pRBC
7/22 BT 65CC pRBC
7/24 APTT 48.1; CONTROL: 33.1;
7/24 PROTIME: 16.8|64|1.35|94%
7/25: HUMAN ALBUMIN TRANSFUSION 50CC 20% HUMAN ALBUMIJN TO
RUN FOR 4 HOURS
7/26 PROTIME: 15.5|72%|1.23|91%
7/31 PROTIME: 15.9|69%|1.27|90%
8/5/18 FOR TRANSFUSION AT 10CC/KG OF PRBC ONCE BLOOD PRODUCTS
ARE AVAILABLE
8/5/18 FOR BLOOD C/S WITH FUNGAL STUDIES
PARACETAMOL 120MG/5ML, 5ML Q4H PRN FOR T>37.8 C (10.4MKD)
7/17 S.NA 135.60| S.K 4.06
7/23 WA UTZ: HEPATOSPLENOMEGALY, GALLBLADDER SLUDGE, URINARY
BLADDER SEDIMENTS, MINIMAL ASCITES, INCIDENTAL FINDING OF
MINIMAL PLEURAL EFFUSION, RIGHT. NORMAL PANCREAS AND KIDNEYS
7/24 BUN: 1.70; CREATININE: 29.39
M 7/5 VITAMIN K 10MG IVTT SLOW RETROGRADE Q8H X 3 DOSES
7/28 VIT K 10MG SLOW IVTT RETROGRADE OD X 3 DOSES
7/28 S. NA 125.30; S.K 3.52
7/31 S.NA 143.40
7/31 TPAG: 68.14|21.37|46.77|0.46
8/1 GIVE VITAMIN K 10 MG SLOW IVTT OD X 3 DAYS
8/5/18 FOR ABDOMINAL SUPINE UPRIGHT XRAY
7/17 FECALYSIS: YELLOW, LOOSE, E. HISTOLYTICA/DISPAR CYST: 1-
4/TROPHOZOITE: 0-2 / E. COLI CYSTS 0-2/TROPH: 0-1/ PUS CELLS 3-8/ RBC
2-5
7/17 URINALYSIS: STRAW, HAZY, PH 6.5, SG 1.020, NEGATIVE SUGAR,
O
NEGATIVE ALBUMIN, 0-2 PUS CELLS, 0-2 RBCS, AMORPHOUS URATES MANY,
SQUAMOUS EPITHELIAL CELLS FEW
7/29 FA: BROWN|FORMED| NO OVA OR PARASITE SEEN
7/31 FA: BROWN|SOFT|NO OVA OR PARASITE SEEN
N
DIET FOR AGE
ZINC SYRUP 5ML OD
D
LACTOBACILLUS SHENKII, CHEW 1 TABLET OD
7/17: HOLD PROBIOTICS
PSWA GANILA, NEONATAL F D5IMB 500 ML X 15-16 CC/HR (TFI 150) VIA SOLUSET (+) EXPOSURE TO BLUE
14 QUEEN RC SEPSIS LATE JAUNDICE LIGHT
R
ARTABA ONSET; AT DIAPER PHOTOTHERAPY
15 HYPERBILIRUBIN I 8/2/18 START AMPICILLIN 125 MG IVTT Q8H (50 MKDOSE) AREA WITH PROPER EYE
8/2/18 START CEFOTAXIME 125 MG IVTT QH (50 MKDOSE)
 DAYS/FEMAL EMIA FOR REPEAT AND GONADAL
C
E/CHILD SECINDARY TO CBC, pH, SHIELD
750470 ABO 8/2/18 BLOOD TYPING: B+ B1B2 MONITOR INPUT
CC: JAUNDICE INCOMPATIBILIT 8/2/18 CBC, PLT OUTPUT Q SHIFT
Y 83/0.21/2.35/24.52/0.49/0.34/0.05/0.11/0.01/35.30/91.40/38.60/814 AND RECORD
DOB: 8/2/18 CRP: <6 MONITOR VS Q4H
7/22/2018 DR. OTICO- 8/2/18 NA: 135.40 K: 5.31 SGPT: 32.47 AND RECORD
DOA: SUNER H 8/2/18 TOTAL BIL: 425.10 DIRECT BIL: 134.50 INDIRECT BIL: 290.6 WATCH OUT AND
8/2/2018 DR. PORTIGO 8/3/18 TOTAL BIL: 371.70/ DIRECT BIL: 147.50/ INDIRECT BIL: 224.2 REFER FOR
8/3/18 RETICULOCYTE COUNT 6.00 SEIZURES, RR > 60
WT: 2.5 KG CC OPENIANO CPM, O2 SAT < 95%,
HT: 51 CM FEVER AND OTHER
UNTOWARD SIGNS
M 8/3/18 AMPICILLIN 125 MG IVTT Q8H/CEFOTAXIME 125 MG IVTT Q8H AND SYMPTOMS
O

D
FOR FOR DISCHARGE
F
DISCHARGE
R

PSWB 2

PSW B = 19
PSWB= 20
PSWB SIVA, NEONATAL F D5 0.3 NACL IL X 20CC/HR (30/6) MONITOR VS Q1H
1 ISAHMI PNEUMONI R O2 AT 3LPM VIA NASAL PRONG WITHOUT FAIL!
QUIHRA A R/O PAI SALBUTAMOL 1/2 NEB + 1CC PNSS THEN Q4H MIO QSHIFT AND
ELISEO SEPSIS CXR PREREAD: BRONCHOPNEUMONIA CONSIDERED RECORD
REPEAT CHEST XRAY WATCHOUT FOR
2M/F/CHILD DR. I TACHYPNEA
VILLARETE C (RR>60CPM),
750352 DR. SILVA H 7/31 CBC: 96/0.29/3.39/24.16/0.44/0.51/0/0.05/0/28.3/86.1/32.8/716 RETRACTIONS, O2
CC M PARACETAMOL 50 MG IVTT Q4H PRN FOR T> 37.8C <95% , DECREASE
CC COUGH PALABRICA O IN ACTIVITY AND
N CARRY OUT CRANIAL ULTRASOUND OTHER
DOB:05/29/18 UNTOWARD S/SX
D FULL TO C
DOA:7/31/18
CBG Q6H
WT: 43KG
HT:53.5 CM
PSWB2 LEGASPI, BRONCHIA F D50.3 NACL 1L X 50CC/HR (MR+10%) VS Q2H WITH
ADDISON L ASTHMA 6 LPM VIA FACEMASK NEURO VS Q2H
AVA IN PAI WITH SALBUTAMOL 1 NEBULE Q6H TO ALTERNATE WITH STRICT MIO
MANGUBAT MODERATE SALBUTAMOL + IPRATROPIUM QSHIFT
2/F/CH ACUTE PAI WITH SALBUTAMOL 1 NEBULE Q4H TO ALTERNATE WITH CHEST
680485 EXACERBA R SALBUTAMOL + IPRATROPIUM PHYSIOTHERAPY
TION HYDROCORTISONE 58 MG IVTT Q8H 5 MKDAY AFTER PAI
DOB: 11/5/15 HYDROCORTISONE 55MG IVTT WATCHOUT FOR
DOA: 7/30/15 DR. TRAYA DECREASED
DR. FOR CXR-APL ON DAY 3 SENSORIUM,
CC: DOB PORTIGO I AMPICILLIN-SULBACTAM 750MG IVTT Q6H ANST (173 MKD) DESATURATION,
CC C CYANOSIS,
HT: 11.5KG PANGANDI 7/30 CBC: HYPOTENSION,
WT: 87CM AN H BRADYCARDIA,
120/0.36/4.71/18.18//0.85/0.11/0.01/0.02/0.01//25.5/76.4/33.4/454
RANITIDINE 20MG IVTT Q8H WHILE ON NPO FEVER, OR ANY
M UNTOWARD SIGNS
7/31: S.NA=144.90, S. K=3.54
O 7/31 UA: PSTRAW/HAZY/7.5/1.020/-/-/1-3/1-4/FEW/FEW AND SYMPTOMS
N
D DIET FOR AGE
PSWB3 PAGUNTALAN, SEPTIC D7.5IMB 500 CC X 19CC/HR (5OML/KG), RE-ASSESS AFTER 6 HOURS HD 14 - VS Q1H W/ NVS
BABY BOY SHOCK, IV SHIFT TO D5IMB 500CC X 15CC/HR (TFI 150) + 2.3CC CALCIUM Q1H
29D/M/NB NEONATAL F GLUCONATE Q SHIFT X 3 DOSES. CEFEP 11 - MIO Q SHIFT
685419 SEPSI, LATE 7/24 INCORPORATE 2.2CC CALCIUM GLUCONATE QSHIFT X 3 SHIFTS. AMIK 13 - CBG Q6H AND
ONSET; 7/29 D5IMB 500CC X 15CC/HR METRO 6 RECORD
DOB: ACUTE CNS START O2 AT 1 LPM FLUC 10+5 - INSERT OGT AND
6/22/2018 INFECTION; 7/19: PH 7.462/PCO2 14.6/ PO2 234/HCO3 10.6/ 10 LPM/ O2 SAT 99.9% ATTACH TO GRAVITY
R
DOA: ELECTROLYTE 7/19 ABG AT 6LPM: PH 7.517/PCO2 15.1/PO2: 164/HCO3 12.2 7/21 CBG = DRAIN.
7/18/2018 IMBALANCE; 7/19 CXR NEONATAL PNEUMONIA, HYPERAERATED LUNGS. EXTREMELY - STANDBY
HIRSCHSPRU FOR PBS,APTT PT LOW INTUBATION SET AND
CC: UPWARD NG DISEASE BLOOS CS AND ABDOMINAL XRAY TAKEN 7/21 S/P DOPAMINE.
ROLLING OF S/P LJUMBAR MEDICATIONS: CEFEPIME WOUND - ABDOMINAL GIRTH
THE EYEBALLS PUNCTURE 8/1 RESTART FLUCONAZOLE 27.5 MG IVTT OD (12 MKDAY) SUTURING MONITORING
S/P IV 7/21 FLUCONAZOLE 14MG IVTT OD THEN 7MG IVTT OD QSHIFT, -REWEIGH
HT: 36 CM CUTDOWN (R I THEREAFTER (3MKDAY) 7/24 QSHIFT
WT: 2.3 KG AND L 7/21 SGPT =265.16 NA DEFICIT REWEIGH EVERY 3
HC: 32 SAPHENOUS 7/24 METRONIDAZOLE IVTT 35MG IVTT A LOADING DOSE NST + DAYS
CC: 33 VEINS) (15MKDAY) THEN 6MG IVTT Q8H AS MAINTENANCE DOSE NST MAINTENAN
AG: 26 DR. TRAYA (7.8MKDAY) CE 6.7MEQ ONCE WITH
BLOOD CS (8/1)- ALARM DETECTED AT 24 HOURS AND 30MINS
DR. PORTIGO = AVAILABLE BLOOD,
C
CC CORRECTIBL PLAN TO TRANSFUSE
REQUEST 1 UNIT PRBC OF PX’S BT AND DIVIDE INTO
PASAPORTE E IN 15 HRS AT 10 CC/KG (23CC)
7/19CBC:
WITH FUROSEMIDE 2
149/0.44/4.46/17.32/0.59/0.31/0.00/0.10/0.00/33.50/98.20/34.10/515
7/30 MG MID OR POST
7/19 BLOOD TYPING: O+
FOR BTX 2 CYCLES 12 HRS
7/19 APTT: 41.9 CONTROL: 32.1 PROTIME: 21.7 % ACT: 43.0 INR:
POSSIBLE APART
H 1.86
7/19 VITAMIN K 3MG VERY SLOW RETROGRADE IVTT OD X PICC
3DAYS INSERTION
7/26 RPT CBC, PLT W/ S. CA ON DAY 10 OF CONTINUITY
7/29 CBC: LAST
97/0.28/2.99/5.61/0.45/0.46/0.02/0.07/0.00/32.60/94.30/34.50/16/17 HYPOGLY
7/31 CBC: 79/0.23/ 2.49/4.41/ 0.42/0.47/0.02/ 0.09/100/31.5/92/34.30/89 EPISODE:
7/19 S.NA: 142.90, S.K: 3.80, S. CA: 1.89 7/30/18
7/21 FOBT (+)
M 7/21 S. CA = 2.00 FOER
7/24 SNA = 134.90 /S. K = 3.69/S.CA=1.88 REPEAT CBC
7/29 S. CA=1.95 PLT ON DAY
7/19 BUN: 18.81, CREATININE: 68.82 3 OF
7/19 U/A: P.STRAW/HAZY/PH 6.5/1.015/SUGAR (-)/ ALBUMIN (-)/ FLUCONAZO
PUS 0-2/RBC 0-2/AM URATES:FEW/ SEC: FEW LE
O
7/28 URINE KOH=NEG FOR FUNGUS
7/24 ABDOMINAL XR: PNEUMATOSIS INTESTINALIS RESOLVED,
GENERALIZED ILEUS.
7/19 CRANIAL UTZ: ESSENTIALLY UNREMARKABLE CRANIAL
N UTZ.
7/20 FOBT = OCCULT BLOOD+
NPO TEMPORARILY
8/1 INCREASE FEEDING BY 1 CC EVERY AFTER FEEDING UNTIL
7/24 START TROPHIC FEEDING 2CC Q3HRS VIA OGT
7/26 FEEDING TO 1CC EVERY OTHER 3 FEEDINGS UNTIL 5CC IS
D REACHED
7/30 INCREASE FEEDING TO 1 CC EVERY OTHER FEEDING
UNTIL 20CC IS ACHIEDSS
FULL TO C

PWSB 4 PAGURAYAN, HIGH GRADE D50.3NACL 1L X 70 CC/H TPR Q4H AND

F RECORD
JAY DEN GLIOMA
9Y/F/CHILD FAVORING R 8/4 CXR: BRONCHOPNEUMONIA MIO Q SHIFT AND
732968 EPYNDEMO 8/4 CEFTRIAXONE 1.5 GMS IVTT Q12H RECORD
MA I NEUROVITAL
OXACILLIN 1.5 GMS IVTT Q6H
CC:FEVER INFECTED SIGNS
C MONITROING
INTRACRANI H 8/4 123/36/29.67/23/20/ REFER
DOB: AL MASS 8/4 PARACETAMOL 250MG/5ML 6ML Q4H
M PERSISTENT
10/20/2008 PCAP C NA: 132.90; K: 3.95; CA: 2.19 FEVER,
DOA: O VOMITING,
8/3/2018 DR. HYPERTENSION
N
MINERVA OR
WT: 28 KG DR. HYPOTENSION,
HT: 117 CM ONGLATCO D NEW ONSET
NEUROLOGIC
CC OTO DEFICIT
PSWB5 CUENCA, PCAP-B F 8/1 D5 0.3 NACL 500 CC TO RUNA AT 25 GTTS/MIN MONITOR INTAKE
ALVINJIE R 8/2 PAI WITH SALBUTAMOL Q 8 HOURS AND OUTPUT Q
3 DR. OTICO- 8/2 02 T 2 LPM VIA NASAL PRONGS SHIFT
MOS/M/CHILD SUNER I AMPICILIN-SULBACTAM 250 MG IVTT Q 6H WATCH OT FAND
750480 DR. PORTIGO C REFER FOR SEIZURES,
CC: COUGH H RR >60 CPM, 02 SAT
CC M 8/2 PARACETAMOL 60 MG IVTT Q 4H FOR TEMP >37.8 <95%, FEVER AND
DOB: PASAPORTE O UNTOWARD SIGNS
N AND SYMPTOMS
 4/20/2018 D FULL TO C
DOA: 8/2/2018

WT: 31KG
HT:131CM
PSWB6 ULAH, NPO TEMPORARILY
MICHEALLA BRONCHIAL F D5 0.3 NACL 1L X 40 ML/HR (MR)
ASTHMA IN INCORPORATE 2 MEQS KCL PER 100 ML IVF
ACUTE O2 AT 10 LPM VIA FACEMASK
R
2 /F/CHILD EXACERBATI ABG AT 10 LPM
734479 ON; PCAP-C I
C CHEST XRAY APL REQUESTED
CC: DOB DR. OTICO- CBC, PLATELET 8/2-
SUNER H 122/0.36/4.60/22/0.88/0.10/0.01/0.01/0/26.60/78.50/33.50/255
DOB:12/16/15 S. NA 140.80 K 3.26, CA 2.36
DOA: 8/2/18 DR. 8/2 PARACETAMOL 100 MG IVTT Q4H PRN FOR T ANST >37.8
PAI WITH 1 NEB SALBUTAMOL Q2H
PORTIGO
HYDROCORTISONE 40 MG IVTT Q6H
WT: 9.7 KG
AMPICILLIN- SULBACTAM 375 MG IVTT Q6H
LT: 81 CM CC M
15 MEQS NAHCO3 AS SLOW IV PUSH THEN 15 MEQS
ULAH, PANGANDIA NAHCO3 AS IV DRIP TO RUN FOR 1 HOUR
MICHEALLA N 1 NEB SALBUTAMOL + IPRATROPIUM Q6H

BRONCHIAL O
2 /F/CHILD ASTHMA IN N
734479 ACUTE D DIET FOR AGE
EXACERBATI
CC: DOB ON; PCAP-C

DOB:12/16/15 DR. OTICO-

DOA: 8/2/18 SUNER

WT: 9.7 KG DR.

LT: 81 CM PORTIGO

CC
PANGANDIA
N
PSWB7 MAYO, AZRHEL BENIGN D5 0.3NACL 1 L + 3 MEQ KCL /100 CC IVF TO RUN AT 50CC/HR ALARM
F
2YO/M/CHILD FEBRILE DETECTE
791625 SEIZURE, R D AT 33
SECONDARY I BLOOD C/S ALARM AT 33 HOURS AND 30 MINUTES HOURS
CC: UPWARD TO C 8/2 CHEST XRAY: BPNA WITH PROGRESSION
ROLLING OF HOSPITAL CBC- 110/0.31/4.30/7.35/0.42/0.07/0.51/0/0/0/25.60/72.90/35.10/ 170
EYEBALLS ASSOCIATED UA- STRAW, HAZY, ALKALIN 7.5, 1.020, TRACE SUGAR, NEG
INFECTION H ALBUM, 1-3, 1-3, FEW, OCC
DOB: FA FFUP
DOA: 8/1/18 DR.MINERV NA 148.00/ K 2.47/2.06
A PARACETAMOL 250 MG/5ML 2.5 ML AT PRN
WT: 13 KG DR. KCL TAB 1 TAB TID X 3 DAYS
M
HT 86 CM ONGLATCO SALBUTAMOL NEBULE 1 NEB EVERY 6 HRS
PARACETAMOL 130 MG IVTT Q4H PRN FEVER >=37.8
CC OCAMPO O

N
D DIET FOR AGE
PSWB ESPINOSA, DICM D5IMB IL X 58 CC.HR (MR) D15 DOI MIO Q SHIFT AND
8 SAMANTHA SEVERE HD 12 RECORD
F
NICOLE SEPSIS, MONITOR VS Q4H
7/F/CH PCAP-D, FOR AND RECORD
753009 SEVERE R 02 AT 1 LPM REPEAT WATCHOUT FOR
DENGUE, 7/21 AMPICILLIN 500 MG IVTT Q6H (113 MKDAY) BLOOD CS PERSISTENCE OF
CC: FEVER UTI S/P PARACETAMOL 250MG/5ML 3.75 ML Q4H PRN FOR FEVER AND FEVER, VOMITING,
MULT. RANITIDINE 18MG IVTT Q8H URINE CS ABDOMINAL PIAN,
DOA: BLOOD OXACILLIN 1.7 G IV Q6HRS EPISTAXIS, GUM
I FOR
7/21/2018 TRANSFUSI AMIKACIN 135 MG IVTT Q12H BLEEDING AND
REPEAT
ON, S/P MEROPENEM 40 MG IV Q8H OTHER UNTOWARD
CBC, PLT
WT: 17.7 ALBUMIN VANCOMYCIN 270 MG IV Q6H SIGNS AND
HT: 118CM TRANSFUSI SYMPTOMS
ON ECG-SINUS TACHYCARDIA
C ECHO- MILD MR, MILD TR, TRIVIAL PR, LVE, MIN,. PERICARDIAL EFFUSION BP AT THE RIGHT LEG:
DR CAPTOPRIL 5 MG/PPTAB 1PPTAB BID SYSTOLE NOT LESS
VILLARETE H 7/27-125/0.37/3.95/13.00/139 THAN 90MMHG
DR SILVA 7/27-125/0.37/3.96/16.20/103
7/26- 136/0.40/4.28/15.60/132
CC PANES 7/25- 119/0.35.3.75/15/40/96 LAST FEVER 8/1/18
7/24-170/0.53/5.45/7.90/24
 NA- 140
K-3.96 (2.41)
M Ca-2.09
BUN-3.08
CREA- 39.79
NO OVA OR PARASITE SEEN IN FECALYSIS
O
STRAW/HZ/7.0/1.015/NEG/TRACE/1-3/10-15
N

D NO DARK COLORED FOOD PLUS EGGWHITE AND BANANA

PSW 10 LINAN, HOSPITAL F D50 0.3 NACL 1LX 30CC/H

JENNYLYN ACQUIRED C/S RESULT
INFECTION PREVIOUS CXR
R
1 /F/CHILD (PNEUMONI CXR RESULT: BRONCHOPNEUMONIA, CONSIDERED.
750432 A) FOLLOW UP IS SUGGESTED
CEFEPIME 350 MG IV Q8 ANST (150 MKD)
CC: FEVER DR. VANCOMYCIN 160 MG IV Q6H NST SLOW IV VIA SOLUSET TO
MINERVA RUN FOR 30 MINS.
DOB:2/12/17 DR. AMIKACIN 150 MG IV OD ANST
DOA: 8/1/18 ONGLATCO CSF GRAM STAIN: 0-1 PUS CELLS
CSF AFB: NEGATIVE FOR FAST ACID BACILLI
CSF KOH: NEGATIVE FOR FUNGUS
WT: 5KG CC OTO
CSF INDIA INK: NEGATIVE CRYPTOCOCCUS NEOFORMANS
LT: 62 CM I CSF PROTEIN: 24.61
CSF AMOUNT: 5.00
COLOR: SLIGHTLY HAZY, BLOOD TINGED (COLORLESS AFTER
CENTRIFUGATION)
CELL COUNT: 2.00
RBC COUNT: 5.00
LYMPHOCYTESl 100
SUGAR: 2.49
SERUM SUGAE: 5.45
C
CBC
87/0.27/3.69/10.40/0.61/0.04/0.24/0.03/0.05/0.00/0.03
H
23.60/72.60/32.40/374
FOR RBS
PARACETAMOL 100 MG/ML, 0.7 ML Q4 PRN FOR T >37.8 C
M
NA = 135.70, K = 4.44, CA 2.26
O
N FOR LUMBAR PUNCTURE ONCE WITH CONSENT
D DIET FOR AGE
PSWB GARCIA, BENIGN F D5 0.3 NACL 1L X 36.37 ML/HR (MR) VIA SOLUSET FOR CUTZ WATCH OUT AND
11 CHELLO FEBRILE DISCONTINUE O2 SUPPLEMENTATION,STANDBY AT BEDSIDE TODAY REFER FOR RR >60
SEIZURE R START PHENYLEPHRINE = CHLORPHENAMINE O2 SAT LESS THAN
684481 SECONDARY SALBUTAMOL 1 NEB EVERY 8 HRS 95
7 TO PCAP A CEFTRIAXONE 900 MG IVTT
I
MOS/M/CHILD FOR LUMBAR PUNCTURE
12/03/2017 DR. OTICO- C
SUNER H
66 CM DR. M PARACETAMOL 90 MGIVTT Q4H PRN FOR MORE THAN 37.8
8.8KG PORTIGO O
N
CC D NPO STARTING 5 AM
OPENIANO
PSWB SAJONIA, NEONATAL IVF: D5 0.3 NACL 1L X 25 CC/H HD22 TPR Q4 AND
12 REVYR PNEUMONI F 7/21 IVF: D50.3NACL 1L 14-15CC/HR (MR+10%) + 2 MEQS KCL/100CC IVF CEFEPIME RECORD
SOLUCIO A 7/28 IVF: D51MB 1L X 14CC/H + 2 MEQS KCL PER 100CC IVF D2 MONITOR FOR
1M/M/CH AMIKACI DESATURATIONS
749574 DR. N D11 REFER FOR
VILLARETE HYDROCO EPISODES OF
DOB: 6/10/18 DR. SILVA RTISONE VOMITING,
D8B/ CYANOSIS,
DOA: 7/10/18 CC PANES
+PREDNIS DESATURATIONS
ONE D3
WT. 3.7KG
HT. 49 CM
PSWB CAPIO, JOHN PCAP C, F D5IMB 1L XX 50 CC/HR (MR) HD 2 TPR Q4
13 JOSHUA SCHIZENCEP O2 AT 2 LPM WATCHOUT FOR
5Y/M/CHIL HALY; NEBULIZE WITH 1NEB SALBUTAMOL 1 NEB Q6H D1+1 UNTOWARD SIGNS
R
525501 CPQS DO LIGHT CHEST PHYSIOTHERAPY AFTER EACH AMPICILLIN AND SYMPTOMS
NEBULIZATION SULBACTAM
I 8/4 AMPICILLIN SULBACTAM 750 MG IV Q6H(153 MKD)
 CC:COUGH DR. C
VILLARETE / 8/4 118/33/10.52/70/20/42/8/3
H
DOB: DR. SILVA
M PARACETAMOL 130 IV Q4 PRN FOR T>37.8
DOA CC O
PALABRICA 8/4 VALPROIC ACID 2MG/5ML, 6ML TID (37 MKD),BACLOFEN
N
WT 13KG 10MG/TAB, 1 TAB BID
HT: 107 CM D FEED WITH STRICT ASPIRATION PRECAUTION
PSW-B PORAL, BABY NEONATAL F IVF: D5 0.3NACL 1L X 27 CC/HR (MR + 10%)] HD 11 QHOURLY WIYTHOUT
14 BOY PNEUMONI AMINOSTERIL 300MG 71CCTO RUN FOR 22 HOURS FAIL SHIFT AND
2 MOS 10 A 08/3 DECREASE IVF RATE TO 14-15CC/HR WHILE ON AMINOSTERIL AMPI D3+1 RECORD
DAYS PAI WITH SALBUTAMOL, ½ NEBULE + 1CC PNSS Q6H CEFOTAX D3 MONITOR VS QH AND
M/CHILD DR. NACL NASAL DROPS, 2 DROPS PER NOSTRIL Q1D +1 RECORD, INCLUDE
685212 VILLARETE HYDROTCORTISONE 20 MG IN O2SAT
DR. SILVA 7/16 CXR PA; NEONATAL PNA CONSIDERED; HYPERRAERATE WATCH OUT FOR
CC: GRUGLY CC 7/19 CXR: NENOATALA PNA WITH PROGRESSION IN RIGHT; DESATURATION,
CHEST PALABRICA HYPERAERATED LUNGS CYANOSIS,
7/26: BRONCHOPNEUMONIA WITH REGRESSION; TACHYPNEA, FEVER,
DOB: R HYPERAERATED LUNGS DECREASED ACTIVITY
05/06/18 7/31: CXR PAL; BRONCHOPNEUMONIA WITH REGRESSION; OR OTHER
HYPERAERATED LUNGS
DOA: UNTOWARD SIGNS
08/3: REVISED NEBULIZATION
07/16/18 AND SYMPTOMS.
SALBUTAMOL NEBULE 1 NEBULE + BUDESONIDE 200MCG/ML
1/2 NEBULE Q12H. SUCTION SECRETIONS
WT: 5.8KG SALBUTAMOL NEBULE 1 NEBULE Q4H WITHOUT FAIL.
HT: SALBUTAMOL + IPATROPIUM Q6H INSTILL 2-3 DROPS OF
HC: 38 CM AMPICILLIN 300 MG IVTT Q8H (50 MKDOSE) NACL NASAL DROPS
AC: 40 CM CEFOTAXIME 300 MG IVTT Q8H (50 MKDOSE) FOR NOSTRIL PRIOR
CC: 41 CM AMPICILLIN 200 MG IVTT Q8H (50 MKDOSE) TO SUCTIONING.
I CEFOTAXIME 200 MG IVTT Q8H (50 MKDOSE)

7/18 CS: GRAM POSITIVE COCCI

7/24 UKOH:
C
7/16 CBC: 104/0.29/3.54/9.07/0.38/0.48/0.06/0.08/0//29.4/83.10
7/22 CBC: 112/0.32/3.53/11.5/0.38/0.03/0.5/0/0.09/0/350
H
7/25 APTT: 27.1/34.3 PROTIME: 13.4/95/1.03/93
7/27 CBC: 136/0.4/4.28/10.5/0.4/0.5/0.02/0.08/0/324
7/18 ABG: METABOLIC ACIDOSIS
M 7/18 ABG: METABOLIC ALKALOSIS
7/25 NA: 139.3 K 5.22 CA 2.06
7/24 FA: YELLOW|SOFT|NO OVA OR PARASITE SEEN
O 7/22 UA: DSTRAW/SHAZY/7/1.010/-/-/20-30/0-2/OCC/OCC
7/25 UA: PSTRAW/HAZY/6.5/1.020/-/-/0-2/0-2/MANY/OCC
7/23 CUTZ: MENINGITIC CHANGES CONSIDERED, PROMINENT
N
VENTRICLES
FEED AS TOLERATED, HOLD FOR RR >/=55 CPM
D
FULL TO C

PSWB SAYCO, PEDIATRIC F HEPLOCK 7/26 FOR MONITOR IO

16 GLEAH MAE COMMUNI O2 AT 8LPM VIA NASAL PRONG; HIGH BACK REST URINE QSHIFT AND
701206 TY 7/22: CXR PAL - CARDIOMEGALY WITH PROGRESSION OF KOH AND RECORD. NO ORAL
10/F ACQUIRED R PULMONARY EDEMA, BILATERAL. INTERCURRENT URINALYS FLUID LIMITATION
PNEUMON PNEUMONIA, BILATERAL, WITH PROGRESSION CONSIDERED. IS MONITOR VS WITH
CC: IA – C; FOLLOW UP SUGGESTED BP AND O2 SAT
DIFFICULTY SUBCLINI CEFEPIME PENDING INFECTIONS CLEARANCE 825MG Q12H, O2 AT QHOURLY AND
OF CAL ANST 7LPM RECORD
BREATHING HYPOTHY I
7/24 START PIPERACILLIN TAZOBACTAM 300MG IVTT Q8H
ROIDISM; AMIKACIN 50MG IVTT Q 24H
 DOB: CHF DIGOXIN 250MG/TAB 1/4TAB BID
04/09/2008 SECONDA FUROSEMIDE 20MG/TAB 1 TAB Q12H WITH BP PRECAUTIONS.
DOA: RY HOLD BP <90/60 MMHG
7/18/2018 PULMONA 7/18 SHIFT FUROSEMIDE TO IVTT 20MG Q12HRS WITH BP
RY PRECAUTIONS
HYPERTEN FOR 2D ECHO - DONE
C
SION ECG: SINUS TACHY, RIGHT AXIS DEVIATION, RIGHT ATRIAL
ENLARGEMENT, RIGHT VENTRICULAR HYPERTROPHY
SILDENAFIL 10MG/PPTAB 1PPTAB BID
DR. ASPIRIN 80MG/TAB 1 TAB OD
MINERVA ALDACTONE 25MG/TAB 1 TAB BID
DR.
ONGLATC 7/18 CBC:
O 139/0.39/4.57/16.83/0.62/0.36/0.01/.01/0.00/30.40/85.40/35.60/360
CC H A
MARTINEZ 7/18 FREE T4: 16.8; TSH: 0.63
7/18NA: 132.20; K: 4.13
PARACETAMOL 250MG/5ML 4 ML Q4H PRN TEMP. >37.8
7/18: NA 132.20, K 4.13
M LEVOTHYROXINE 25MCG/TAB 1 ½ TAB OD IN AM TO BE GIVEN
SAME TIME EVERYDAY
MUPIROCIN ON PREV IV LINE TID
7/18 UA: DSTRAW/ HAZY/ 5.5/ 1.025// SUG ALB -/0-3/ RBC 10-20/
O
FEW/ MANY
N
SMALL FREQUENT FEEDINGS
D
FULL TO C
PSWB SAMPORNA, NEONATA F 7/30 D5 0.3NACL 1L X 28CC/HR (TFI 150) + 2 MEQS MIO QSHIFT
17 MOHAMMA L KCL/100CC/IVF MONITOR VS Q4HR
CRIB 1 D PNEUMON R 8/3O2 AT 1LPM VIA NASAL PRONGS AND RECORD
MACAPANT IA 7/30 PAI WITH SALBUTAMOL 1 NEB Q4H; CHEST SUCTIONSECRETI
ON PHYSIOTHERAPY THEREAFTER ONS PRN
1MO/M/CH DR. TRAYA 7/30 CXR APL BRONCHPNEUMONIA, HAL W/O FOR
750348 DR. I 08/3 SHIFT AMPICILLIN AND CEFOTAXIME 225 MG IVTT Q12H DESATURATIONS,
PORTIGO NST TO AMIKACIN 60 MG IVTT Q24 NST SIGNS OF
DOB: CC C RESPIRATPRY FAILURE
6/19/2018 OPENIANO H 7/30 CBC,PLT 115/0.33/3.57/24.98/0.13 (STAB 0.12)/0.61(REACTV (CYANOSIS,
DOA: 0.05)/0.00/0.09/0.00/32.10`/92.30/34.80/293 GRUNTING,APNEA,
7/30/2018 M 7/30 CBG Q8HR WHILE ON NPO DECREASED IN
O SENSORIUM
CC: COUGH N
D FULL TO C
HT: 49 CM
WT: 4.5 KG
HC: 36.5 CM
CC: 37 CM
AG: 37 CM

PSWB CAJURAO, NEONATA F D5IMB 1L X 12CC/HR HD 5 EXPOSE UNDER

18 BB BOY L SEPSIS BLUELIGJT
CRIB 2 ALINTANO EARLY R O2 AT 1LPM VIA NASAL PRONG PHOTHERAPY
0/M/CH ONSET DISCONTINUE 02 WITH PROPER EYE
750024 I AMPICILLIN 160MG IVTT Q12H NST(50MKDAY) AND GONADAL
DR TRAYA CEFOTAXIME 160MG IVTT Q12H NST (50MKDAY SHIELD.
CC: SEIZURE DR. C MIO Q SHIFT &
DOB: PORTIGO RECORD.
7/21/2018 CC H BLOOD TYPE: A+ MONITOR VS AND
DOA: MURILLO RECORD.
7/21/2018 M 7/21 NA: 136.1; K: 4.74; CA:2.13 WATCHOUT FOR
7/21 TOTAL BILIRUBIN: 260.80; B1:13.8; B2: 247 POOR SUCK,
WT: 3.2 KG 7/23 TOTAL BILIRUBIN 327.70; B1 19.60; B2 305.1 JAUNDICE
HT: 49CM 7/26 TOTAL BILIRUBIN 248.50; B1 13.20; B2 235.3 PROGRESSION,
HC: 34 O 7/23 UTZ: UNDESCENDED TESTIS R.; PATENT PROCESSUS DYSPNEA,
CC: 34 VAGINALIS, BILATERAL; MINIMAL HYDROCOEL TACHYPNEA,
AG: 33 N DESATURATIONS,
AND OTHE
D BREASTFEED PER CDEMAND WITH STRICT ASPIRATION UNTOWRD SIGNS
PRECAUTIONS, HOLD FOR RR≥60 AND SYMPTOMS
FULL TO C
PSW B DINGCONG, NEONATA F 8/2 D5IMB 500 CC X 28 CC/HOUR
19 CATHALEYA L
CRIB 3 MARIE PNEUMON 8/2 SALBUTAMOL 1/2 NEBULE + 1 CC NSS Q 6 HOURS
1MOS/F/CHIL IA R/O R SALINASE NASAL DROPS 2-3 DROPS TID
D NEONATA O2 AT 1 LPM
L SEPSIS 8/2 AMPICILLIN 225 MG IV Q 8HOURS NST
CC: COUGH VERY I 8/2 CEFOTAXIME 225 MG IV Q8 NST
LATE 8/2 C REACTIVE PROTEIN: <6
ONSET C

DR. 8/2 CBC 100, 0.29, 3.33, 12.25, 0.39, 0.48, 0.05, 0.08, 0.00, 30.00, 86.20,
H
MINERVA 34.80, 784
M 8/2 NA-139.40, K-6.05, CALCIUM-2.50
CC
O
PATANGA
 N N

D FULL TO C

PEDIA ISOL= 3
DIAGNOSIS
ROO PATIENT PENDING/SPECIAL
CIC/RIC/CCI MANAGEMENT UPDATES
M DATA ORDERS
C
F HEPLOCK
CANDEL,
R
ENZO VENTRICULITIS
CEFTRIAXONE 680MG IVTT Q24H (100MKDAY)
MAGBANUA TPR Q4H
I OXACILLIN 340MG IVTT Q6H NST (200MKDAY)
4MO/M/CH MIO QSHIFT
P- BLOOD CS (7/27)- NO GROWTH AFTER 7 DAYS
738726 DR TRAYA WOF FEVER,
ISOL C
DR PORTIGO SEIZURES, POOR
1 CBC: 118/0.35/4.47/16.35/0.13/0.76/0.04/0.06/0.01/26.40/79/33.40/483
CC: CC H SUCK, IRRITABILITY
BLOOD &S
VENTRICULIT PANGANDIA AND OTHER SSX
M
IS IN UTZ N
O 7/27 UA: P.STRAW/HAZY/PH 6.0/SUGAR=NEG/ALBUMIN=NEG/
N RPT CRANIAL UTZ
P-ISOL MORONG, HCAI- F SALINE LOCK
2 BEA REYES PNEUMONIA R
14/F/CH CKD STAGE I URINE KOH: NEGATIVE
748634 V; 7/31 BLOOD CS: MRSA VS Q4H AND RECORD
CONCEPCI ELECTROLYT C MIO Q SHIFT
ON, ILOILO E H CBC(07/25/2018): 121|0.345|4.33|27.06|0.89|0.04|0.03|0.04|0|27.80|81.70|34|102 PLAN TO FOR HEMODIALYSIS
IMBALANCE 7/28 CBC: 106/0.31/3.93/19.38//0.87/0.07/0.02/0.04/0//27.1/79.5/34.1/121 DO AVF IN TOMORROW
8/1: BT 1’0’’; CT: 3’00’’ LEFT WATCH OUT FOR
DOB:3/11/2
M S. CREATININE ANTECUBI DOB, FEVER
004 DR. TRAYA CEFTAZIDIME 3.5MG IVTT Q24H
DOA: DR. PORTIGO TAL ARE RECURRENCE,
OXACILLIN 650MG IVTT Q6H
7/25/18 AMLODIPINE 5MG/TAB, 1 TAB OD PO SAVE LEFT DESATURAYTIONS,
CC NAHCO3 325MG/TAB, 1 TAB TIDPO ARM DECREASED
PASAPORTE CACO3 TAB, 1 TAB OD PO SENSORIUM OR ANY
7/28 CREA: 430.79 UNTOWARD SIGNS
O U/A (07/26/18): STRAW|HAZY|PH8.0|1.015|TRACE|1+| |10-15|40-60|FEW| OR SYMPTOMS
MANY|FEW
N
D LOW FAT DIET
P- AGREGAD ANEMIA, NO LINE FOR NOW: START PNSS @ KVO ONCE PRBC IS VS Q4H AND RECORD
F
ISOL O, ANLYN ETILOGY TO AVAILABLE; HEPLOCK AFTER 1L MIO QSHIFT AND
3 GRACE BE R RECORD
ISARE DETERIMINE CRP: <6 O2 AT 1 LPM VIA NP
15/F/CHILD D; NON URINE KOH: NEGATIVE
749737 OBSTRUCTIN BLOOD CULTURE: NO GROWTH FOR POSSIBLE
G STOOL CULTURE AND SENSITIVITY: MODERATELY HEAVY CARDIO REFERRAL IF
CC: FEVER NEPHROLITH GROWTH OF RAOULTELLA ORNITHINOLYTICA (SENSITIVE TO: WITH ABNORMAL 2D
IASIS, I ECHO FINDINGS
AMIKACIN, CEFTAZIDIME, CEFEPIME, CEFTRIAXONE,
DOB: BILATERAL; CEFUROXIME, GENTAMYCIN, MEROPENEM)
8/17/2002 DOWN TUBEX: NEGATIVE TO WEAR MASK AT
DOA: SYNDROME; CEFTRIAXONE 1.5GMIVTT Q12H ANST ALL TIMES
7/15/2018 RULE OUT AMIKACIN 450MG IVTT OD (15MKD)
CML C ECG: SINUS TACHYCARDIA; NORMAL ABDOMINAL GIRTH
WT: 30KG 2D ECHO: MONITORING OD
HT: 133 CM DR. TRAYA CONGENITAL HEART DISEASE, TINY PATENT DUCTUS
DR. PORTIGO ARTERIOSUS
CC TRIVIAL MITRAL REGURGITATION
OQUENDO MILD TRICUSPID AND PULMONARY REGURGITATION
GOOD CARDIAC CONTRACTILITY
NORMAL CHAMBER DIMENSIONS
 O+
7/14 CBC: 100/0.29/3.1/14/9//SEG 0.88/LYMPH0.10/THRO 486
7/15 CBC:
69/0.24/2.90/19.24//0.84/0.09/0.01/0.06/0//23.9/82.80/28.80/584
7/15 ESR 140
7/15 RETIC COUNT 27
7/17 CBC:
91/0.29/91/3.54/17.89//0.89/0.05/0.01/0.05/0//25.6/82.4/31.1/520
FOBT- POSITIVE
S/P 2 UNITS 150CC PRBC TRANSFUSION
PBS: 68|0.22|2.71|15.34|81/7|2|10|25|82.3|30.40|342; (+++)
MICROCYTES, (++) OVALOCYTES AND POLYCHROMATOPHILIA,
H (+) ANULOCYTE, SPHEROCYTE, TEAR DROP CELL, &
ELLIPTOCYTE.
SEVERE ANEMIA WITH MICROCYTIC, HYPOCHROMIC
ERYTHROCYTES BY MORPHOLOGY. MODERATE
ANISOPOIKILOCYTOSIS, AND MODERATE
POLYCHROMATOPHILIA
LEUKOCYTOSIS WITH ABSOLUTE NEUTROPHILIA AND
MONOCYTOSIS
ADEQUATE PLATELET COUNT WITH NORMAL PLATELET
MORPHOLOGY
CBC (7/22/18): 89|0.28|3.37|20.09|0.87|0.07|0.01|0.05|0|26.40| 83.30|
31.70|520
CBC, PLT
WA-UTZ: HEPATOMEGALY WITH DIFFUSE HEPATIC
PARENCHYMAL DISEASE
BILATERAL PELVOCALIECTASIA WITH NEPHROLITHISES
RIGHT ADNEXAL CYST WITH SEPTATIONS, PROBABLY
OVARIAN IN ORIGIN. TRANSVAGINAL ULTRASOUND
SUGGESTED FOR FURTHER EVALUATION
MINIMAL ASCITES
M
NORMAL GALLBLADDER, PANCREAS AND SPLEEN
ULTRASONOGRAPHICALLY
TR-UTZ:
CREATININE: 84.07
BLOOD UREA NITROGEN: 5.11
CA-125

7/14 UA:STRAW/ SLIGHTLY HAZY/6.0/1.030/NEG SUGAR,

TRACE ALB/ RBC 1-2/ WBC 1-3
O 7/15 UA: PSTRAW/HAZY/5.0/1.020/-/-/0-2/0-2/FEW/FEW
7/15 BUN: 5.11 CREA: 84.07
OCCULT BLOOD: POSITIVE
N
D DIET AS TOLERATED

THIRD FLOOR= 1
ROO PATIENT DIAGNOSIS PENDING/SPECIA
MANAGEMENT UPDATES
M DATA CIC/RIC/CCIC L ORDERS
311 MONINO, NEONATAL F D5 IMB X 16-17 PER HOUR
DIANA SEPSIS - R NaCl nasal spray 1-2sprays per nostril prn for nasal
MARGAUX LATE ONSET; secretion S/P
26d/F R/O ACUTE SALBUTAMOL 1/2 + 1ML NSS LUMBAR
750075 CNS I AMPICILLIN 500 MG IVTT Q8H NST PUNCTUR Monitor IO
CC: FEVER INFECTION CEFOTAXIME 200 MG IVTT Q8H NST E QSHIFT
C MONITOR VS
H VITAMIN K 8/4 Q4H
M Q4H
O Today
N Cranial UTZ: Essentially normal findings stable VS
D DAT
D

FOURTH FLOOR= 3
ROO PATIENT DIAGNOSIS PENDING/SPECIA
MANAGEMENT UPDATES
M DATA CIC/RIC/CCIC L ORDERS
409 PANES, COMPLEX F D50 0.3 NACL 1L X 45CC/HR 8/4 TPR Q4 AND
GEN BENIGN R STANDING O2 AT BEDSIDE Q1H with RECORD
GABRIEL FEBRILE I CEFTRIAZONE 425 IVTT Q12H neuro VS MONITOR NVS
2/M SEIZURE C WITH BP
3750497 SECONDARY H QHOURLY AND
TO M PARACETAMOL 90MG IV Q4 RTC RECORD
CC: BRONCHOPN O
UPWARD UEMONIA N PHENOBARBITAL 130 MG IV AS LOADING DOSE THEN 20
ACTIVITY MG IV Q12 HOURS THERE AFTER
OF DR. STANDBY MDIAZOLAM 1.7 MG FOR FRANK SEIZURE
 EYEBALLS DIVINAGRACI
A
DOB:
D
4/1/2016 DR. SILVA
DOA:
8/3/2018
412 DEMEGILL DENGUE F IVF D5LR X 150 CC/HOUR 8/4 WATCH OUT FOR
O, DANE WITH R Q2H HYPOTENSION,
ANDREW WARNING I NS1- positive Today TACHYCARDIA
MOSPA SIGNS C stable VS AND BLEEDING
13/M/CHIL H 137/0.40/4.69/1.94/159/ diff. ct referred except EPISODES
D DR. MIBERVA M Na- 140.20 K- 3.65 Ca- 1.93 HYPOTEN
555792 DR. Calcium gluconate 10meqs SION,
ONGLATCO O REFER
CC: FEVER
N
D DIET FOR AGE EXCEPT DARK COLORED STOOLS
DOB:
02/10/200
5
DOA:
08/02/201
8
420 CHAN, ACUTE F RIGHT HAND: PLR 1L X KVO 8/5 REFER
KARYLL GASTROENTE LEFT HAND: D5LR 1L X 150CC/HR Q4H then UNTOWARD
JOYCE RITIS WITH R record SSXSUCH AS
17/F SEVERE Today HYPOTENSION,
394880 DEHYDRATIO I stable VS PERSISTENT
N LOOSE STOOLS
CC: C AND VOMITING,
VOMITING DR. TACHYCARDIA
AND INOSANTO H
LOOSE DR. NPOX
STOOLS ONGLATCO M RANITIDINE 50mg IVTT Q8H
METOCLOPROMIDE 10mg IVTT PRN FOR VOMITING
DOB:
O
9/24/2000
DOA:
08/05/201 N
8
D

PICU = 2
ROO PATIENT DIAGNOSIS PENDING/SPECIAL
MANAGEMENT UPDATES
M DATA CIC/RIC/CCIC ORDERS
PICU 1 ARROYO , NEONATAL WITH UMBILICAL CATHETER: D10W 500CC X 8-9CC/HR (TFI 70) Reweigh QHOURLY VS
THEO OLIVER PNEUMONIA; HEPLOCK patient in Q4H BLOOD
F AM PRESSURE,
14D/M/CH HYPOXIC IVF: D5IMB 500mL X 14mL/Hr
749673 ISCHEMIC DC IVF rate and shift to heplock once 30cc Q3H feeding is reached REFER FOR
ENCEPHALOPAT CXR: WITH INFILTRATES ABDOMIN SYSTOLE > 90
DOB: 7/13/18 HY STAGE 1; TO WITH ET SIZE 3, LEVEL 9; FIO2 90%; ON CPAP AL GIRTH WOF:
(5AM) RULE OUT MONITORI TACHYPNEA
Pai w/ salbutamol 1/2neb then q20min x2dosesmore
NG QSHIT (RR>60);
DOA: NEONATAL D/C Nasal CPAPand shift to O2 at 2lpm vianasal prongs
DESATURATION
7/13/18 SEPSIS, EARLY R O2 AT 1LPM For BCG (O2<95%),
ONSET NACL NASAL DROPS 2.3 DROPS PER NOSTRIL TID THEN SUCTION anytime RETRACTIONS,
S/P CTT FACE MASK: DECREASE FIO2 65 THEN 60 AFTER 12HRS prior to ALAR FLARING,
INSERTION, 07/30 D/C O2 SUPPLEMENT discharge. CYANOSIS, DEC
RIGHT IN ACTIVITY.
S/P BLOOD AMPICILLIN 14mg IVTT Q12H (50 mkdose)
TRANSFUSION Ceftriaxone 145 mg IVTT Q12H (50mk dose)
S/P FFP CEFEPIME 155MG IVTT Q12H(50MKDOSE)
TRANSFUSION I
AMIKACIN 50MG IVTT Q24H(15MKDOSE)
OXACILLIN 155 MG IVTT Q12H (50MKDOSE)

DR. ALVIAR C
DR. VARON 7/22 S/P FFP TRANSFUSION 45CC
CC MONSALE H
7/23 S/P FFP TRANSFUSION 45 CC
Vit K 1mg deep IM
Hep B 0.5mL deep IM
Teramycin Eye ointment
M 7/20 Vitamin K 1mg IM now then q5days while on antibiotics
7/22 For Urine KOH
7/25 Rpt Urinalysis
Cbg MONITORING Q12
O
PHENOBARBITAL 50 MG IVTT Q12H(3.22 MKD)
7/25 DC IV Citicholine and shift to Oral Cetirizine 100mg/mL, 0.4 mL BID
N
(20mkday)
EEG PRIOR TO DISCHARGE
 7/25 Start PO Feeding by 5cc Q3H, OGT Feeding at 25cc Q3H with strict
aspiration precautions.
Once 5cc PO feeding x 3 determinations are tolerated, ↑ PO feeding by
5cc every other feeding until 30cc Q3H PO is reached. Adjust OGT
D
feedings accordingly to make a total of 30cc Q3H feeding.
Pull out OGT once 30cc Q3H PO is reached
MAY BREASTFEED
7/29 NPO
ALEBIANO, DENGUE FEVER F IVF 130CC/HR (mr) Close monitoring of
PICU- ALEXANDRA WITH WARNING R BP
ISOL 18/F/S SIGNS I Narrow pulse
750387 C DOPAMINE DRIP (10MG/KG/MIN) pressure
H 175/0.47/5.76/4.21/12/ REACTIVE LYMPHOCYTES
CC: FEVER M K= 3.76
AND O
VOMITTING N
7/31/18
D
WT: 60.5
HT: 159 CM

SICU = 2
PATIENT DIAGNOSIS PENDING/SPECIAL
ROOM MANAGEMENT UPDATES
DATA CIC/RIC/CCIC ORDERS
SICU 1 F HEPLOCK INCREASE
ANTIBIOTICS TO
R
LAMSIN, Q8H AT D8
AMPICILLIN 125 MH IVTT Q12H (50 MKDOSE)
ALJHONE I
CEFOTAXIME 125 MG IVTT Q12H (50 MKDOSE) MAINTAIN TEMP
PATROLERO
C AT 36.5-37.5 (PUT
4 D.O. /M/CH
MYELOMENING 7/26 CBC: 187/0.55/5.89/9.6//0.44/0.56/0/0/0/176 UNDER DROP
761922 H
OCELE 7/26 APTT: 36.61/34.7// PROTIME: 12.4/100/1/91 LIGHT IF
M 7/26 NA: 138 K:4.72 HYPOTHERMIC
CC: SACRAL
DR. MINERVA
BULGE O
DR. VARON
CT SCAN PRE READ: VENTRICULOMEGALY PROBABLY
DOA: N SECONDARY TO AQUEDUCTAL STENOSIS; CEREBRAL
7/26/2018 EDEMA; SEMILOBAR HOLOPROSENCEPHALY, CONSIDERED
DOB: AS TOLERATED
7/22/2018 D

SICU 2 HISU-AN F D5 LR 1 L X 125 CC/HR MONITOR VS

JAMAICA R CHEST XRAY DONE Q4H AND
EBUS RECORD.
I CEFUROXIME 750 MG IVTT Q8H MIO QSHIFT
9/F BLUNT
750280 C REFER ACCOR
ABDOMINAL
7/28/18 H “B” POSITIVE DINGLY.
TRAUMA
CBC 127/0.38/4.8/12.70/0.81/0.12/0.01/0.06/0.00/26.40/78.80/33.5/439
CC: DR VARON M NA 134.70
ABDOMINAL K 4.27
PAIN O RANITIDINE 25 MG IV Q8H
N
D NPO

ICU ISOL = 0
ROO PATIENT DIAGNOSIS PENDING/SPECIAL
MANAGEMENT UPDATES
M DATA CIC/RIC/CCIC ORDERS
F
R
I
C
H
M
O
N
D

STA. TERESITA = 8
PATIENT DIAGNOSIS
ROOM MANAGEMENT UPDATES SPECIAL ORDERS
DATA CIC/RIC/CCIC
102 A BERNARDO, DENGUE FEVER F D5LR IL X 150 CC/hr + 3 MEQS KCL PER 100 cc of IVF MIO QSHIFT AND
ANNA WITH WARNING R RECORD
MARGARITA SIGNS I Paracetamol 500 mg tab 1 tab Q4H PRN for temp >37.8 MONITOR VS Q4H
TABION Ranitidine 50 mg IVTT Q8H AND RECORD
16/F/C WATCH OUT FOR
C
750325 HYPOTENSION
H CBC PLATELET DONE NARROW PULSE
M PRESSURE ,
CC:FEVER O
 N
AND RASH D FEVER
102 B AKIAPAT BB EXAGERATED F D5IMB 500 ML 18-19 CC/HR VIA SOLUSET LABS TACHYCARDIA
TPR Q4H AND
BOY JAUNDICE R TAKEN : CRP RECORD
CABASAL/4 SECONDARY I PHOTOTHERAPY BILIRUBIN BREASTFEEDING
DAYS/M/C TO ABO C LEVELS WITH STRICT
685574 INCOMPATIBI H CBC PLATELET DONE ASPIRATION
LITY M TOTAL PERCUSSION
CC: O BILIRUBIN:
YELLOWISH N 109.30
DISCOLORATI D DIRECT
ON BILIRUBIN:
6.10
INDIRECT
BILIRUBIN:
103.2

102 C DURAN SYSTEMIC VIRAL F D5LR 1L X 100CC/H

RUTICHIE INFECTION R/O 8/2 START ON N-ACETYL CYSTEINE 600MG/TAB, DISSOLVED IN 1/2 GLASS
R
17/F/CHILD DENGUE FEVER OF WATER ONCE A DAY AT BETIME
750463 8/2 FOR BLOOD CS, FOR URINE CS
I
DR: FAULAN
CC: FEVER DR. PORTIGO C
DOB: H
09/18/2000
DOA: M 8/3 FOR AN, LDH, C3, ESR, CRP, RHEUMATOID FACTOR
8/2/2018
O
WT: 37 KG
HT: 152 CM N

D
102 D NGU, ASHLEE NON 8/3 D50.3NACL IL X 150CC/HR STRICT INPUT
F
11/F/CHILD ULCERATIVE PLEASZE GIVEPLR 300CC AS FD OUTPUT
511241 DYSPEPSIA 8/3 START HEXETIDINE ORAL SOLUTION SINGLE TID MONITORING
R
CC: DR. VILLARETE I 8/3 START AMPICILLIN 1GM IV Q6H
VOMITING DR. SILVA
C
DOB:
10/27/2006 H
DOA:
8/2/2018 M

WT: 37.5 KG O
HT: 5'8 FT
N

D MAY HAVE SOFT DIET

103 A GULA, MARIA PEDIATRIC D5NSS 1L X 50 CC/HR MIO Q SHIFT AND
F
ISABELLE COMMUNITY RECORD
3/F/CJHILD ACQUIRED R 7/30 SALBUTAMOL 1 NEB + BIDESONIDE 500 MG/TAB MONITOR VS Q4H
528057 PNEUOMINA WATCHOUT FOR
MODERATE RISK 7/30 CEFTRIAXONE 1.6 GM IVTT NOW THEN Q24H ABDOMINAL PAIN
I
CC: FEVER PCAP C; 7/31 NS1 DENGUE ANTIGEN AND DOT IGG IGM - NEG BLEEDING
ENTERIC FEVER C HYPOTENSION,
DOB: NARROW PULSE
6/8/2014 DR. SILLA H 7/31 128/0.35/4.61/2.60/22/60/9/4/27.70/76.50/36.10/152 PRESSURE
DOA:
7/30 PARACETAMOL 250 MG/5ML Q4H
7/30/2018 M

O 7/31 UA: STRAW/HAZY/7.0/NEG/NEG/0-2/0-2/OCC/OCC

WT:

D
103 B ESCULTOR, PCAP C F D50.3NACL 500ML X 35 CC/HR MONITOR VS Q4H
JOHN MIO Q SHIFT AND
MATTHEW DR. R 8/1 O2 AT 2LPM VIA NASAL CANNULA, SALBUMATOL 1 NEB Q6H RECORD
7 DIVINAGRACIA 8/1 START ON AMPICILLIN-SULBACTAM 375 MG IVTT Q8H, WATCHOUT FOR
MONTHS/M/ I TACHYPNEA (RR>50)
HYDROCORTISONE 40MG IVTT Q6H
CHILD DESATURATION,
C CYANOSIS,
CC: FAST H 7/31 110/0.34/4.60/11.49/29/2/58/1/10/24/74.20/32.30 RRETRACTIONS AND
 BREATHING M DECREASE
SENSORIUM
DOB: O
12/08/2017
DOA: N
7/31/2018 .
D
LT:
WT:
103 C GARGOLES, DENGUE FEVER F D5LR 1LX120CC/HR
REYSIE MAE WITH WARNING
18/F/CHILD SIGNS R/O UTI R

I
CC: FEVER
C

M PARACETAMOL 500MG/TAB 1, 1 TAB Q4H

103 D GABAYOYO, POST- F

AUDREY, JOY STREPTOCOCCA
7/F/CHILD L R
GLOMERULONE I CEFUROXIME 750MG IVTT Q8H
CC: GROSS PHRITIS PCAP -
HEMATURIA LOW RISK C

DOB: DR. PUIG-REYES H

09/20/2010 M FUROSEMIDE 30 MG IVTT Q12H
DOA:
7/31/2018 O

WT:32.5 KG N
HT: 127.1CM D LOW SALT DIET

SAN LORENZO RUIZ WARD (SURGICAL WARD) = 1

ROO PATIENT DIAGNOSIS
MANAGEMENT UPDATES SPECIAL ORDERS
M DATA CIC/RIC/CCIC

ST. CAMILLUS = 4
DIAGNOSIS
ROO PATIENT
CIC/RIC/CCI MANAGEMENT UPDATES SPECIAL ORDERS
M DATA
C
SC4A CAYETANO, WDX: F ON HEPLOCK U/A TPR Q1
ANGELO ACUTE R RESULTS, VS QHOURLT
7/M GLOMERUL I CEFUROXIME 250/5ML, 6ML BID C3 STRICT I/O
762005 ONEPHRITIS C DETERMIN MONITORING
H CLONIDINE 75MCG/TAB, 1 TAB IF BP>120/80 ATION WATCH OUT FOR
CC SWOLLEN M FUROSEMIDE 4MG TAB Q8H INCREASED BP, DOB,
TESTIS O EDEMA, TACHYPNEA,
N OTHER UNTOWARD
SIGNS/SYMPTOM
D NO DARK COLORED FOODS
LIMIT FLUIDS TO 650 CC/HR
SCW PORMIENTO, AGE WITH F D5LR 60CC/HR TPR Q4
4B XYZER MILD MIO QSHIFT
R
CAMATO DEHYDRATI STOOL COUNT AT
2/M ON I BEDSIDE
661672 C MONITOR VS Q4H
DR. WATCH OUT FOR
H SIGNS AND
CC VILLARUZ
M SYMPTOMS OF
DR.
O DEHYDRATION
DOB: PORTIGO
 07/01/16 N
DOA:
08/02/18
D DIET FOR AGE

SCW PUNIEL, DENGUE F IVF: D5LR X 140 CC/HR (3CC/KG) MIO QSHIFT AND
6A GERZEN FEVER WITH RECORD
R
ZACAHARY WARNING MONITOR VS Q4H
13/M/CH SIGNS I AND RECORD
601403 C WATCH OUT FOR
PASSI CITY, DR. ALCALA ABDOMINAL PAIN,
H GUM BLEEDING
ILOILO DR. PALEC
M EPISTAXIS,
HYPOTENSION,
DOB: O
NARROW PULSE
8/15/2004 N PRESSURE, OR
DOA: OTHER UNTOWARD
7/30/18 SIGNS AND
D DAT, NO DARK COLORED FOOD AND DRINKS SYMPTOMS
WT: 46.2 KG

SCW DEMONTEVE DENGUE F D5LR 1L X 50MCC/HR MONITOR VS Q4

6B RDE, ANNIKA FEVER WITH WATCH OUT FOR:
R
LEINNE WARNING BP <80, NARROW
3/F SIGNS I MUPIROCIN AT IV SITE TID PULSE PRESSURE,
750396 C PERSISTENT
DR. ABDOMINAL PAIN,
H BLEEDING GUMS,
CC FEVER COLACION
M PARACETAMOL 250 MG/DML 2.5 ML Q4H COLD CLAMMY
DR. SILVA
EXTREMITIES,
DOB: O
POORLY PERFUSED
07/25/2015 N EXTREMITIES
DOA: UO MONITORING
07/31/2018 D DIET FOR AGE, NO DARK COLORED FOOD

MORTALITY
ROO PATIENT DIAGNOSIS
MANAGEMENT UPDATES SPECIAL ORDERS
M DATA CIC/RIC/CCIC

DISCHARGED=
ROO PATIENT DIAGNOSIS
MANAGEMENT UPDATES SPECIAL ORDERS
M DATA CIC/RIC/CCIC
PSW-B MASICAMPO ACUTE F D5LR 1L X 80CC/H + 3 MEQS KCL/100CC IVF MGH MONITOR Q4H
12 AIMEREE GASTROE WATCH OUT FOR
TO EVE NTERITIS R DECREASED
PSW A VILLAREAL WITH ACTIVITY,
I AMPICILLING 250 MG IVTT Q6H
1/F/CH MODERAT VOMITING, LOOSE
750329 E STOOL,
DEHYDRA C HYPOTENSION
DOB: 10/1/16 TION; 7/30 CBC: VOMITUS AND
DOA: 7/29/18 PCAP B; H STOOL COUNT AT
117/0.30/4.28/7.65//0.61/0.30/0.00/0.09/0.00//27.40/71.00/38.60/465
HYPOKAL KCL TAB 1 TAB PO TID BEDSIDE
CC: LOOSE EMIA M
PLR TO REPLACE GI LOSSES PER VOLUME
STOOLS SECONDA 7/29 FECALYSIS: GRN/MUCOID/NO OVA/ MANY/0-3/1-3
RY O
HTL 78CM N
WT: 9.2KG DR.
MINERVA
DR.
ONGLATC
O D
CC
PATANGA
N